{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:17:19Z","timestamp":1789179439516,"version":"build-2803163510"},"reference-count":481,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.prp.2025.156109","type":"journal-article","created":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T02:47:28Z","timestamp":1751683648000},"page":"156109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Unravelling the Alzheimer's pathogenesis: Molecular and cellular pathways to neurodegeneration and therapeutic targets"],"prefix":"10.1016","volume":"272","author":[{"given":"Payal","family":"Chauhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karan","family":"Wadhwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7906-5744","authenticated-orcid":false,"given":"Govind","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2025.156109_bib1","first-page":"1","article-title":"Global burden of Alzheimer\u2019s disease and other dementias during 1990-2021: a Global Burden of Disease and Risk Factors Study 2021-based study","author":"Wang","year":"2025","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.prp.2025.156109_bib2","article-title":"2025 Alzheimer\u2019s disease facts and figures","volume":"21","year":"2025","journal-title":"Alzheimer\u2019S. Dement"},{"key":"10.1016\/j.prp.2025.156109_bib3","first-page":"154","article-title":"Diverse models in Alzheimer\u2019s research: exploring alternative approaches beyond traditional rodent frameworks","volume":"6","author":"Chauhan","year":"2024","journal-title":"Aging Pathobiol. Ther."},{"key":"10.1016\/j.prp.2025.156109_bib4","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm1782","article-title":"Amyloid-beta protein dimers isolated directly from Alzheimer\u2019s brains impair synaptic plasticity and memory","volume":"14","author":"Shankar","year":"2008","journal-title":"Nat. Med"},{"key":"10.1016\/j.prp.2025.156109_bib5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid \u03b2-peptide","volume":"8","author":"Haass","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.prp.2025.156109_bib6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fnano.2022.1018754","article-title":"Caenorhabditis elegans as a model system to evaluate neuroprotective potential of nano formulations","volume":"4","author":"Chauhan","year":"2022","journal-title":"Front Nanotechnol."},{"key":"10.1016\/j.prp.2025.156109_bib7","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2589276","article-title":"Therapies for prevention and treatment of Alzheimer\u2019s disease","volume":"2016","author":"Mendiola-Precoma","year":"2016","journal-title":"Biomed. Res Int"},{"key":"10.1016\/j.prp.2025.156109_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102481","article-title":"Pathogenesis, diagnostics, and therapeutics for Alzheimer\u2019s disease: breaking the memory barrier","volume":"101","author":"Kamatham","year":"2024","journal-title":"Ageing Res Rev."},{"key":"10.1016\/j.prp.2025.156109_bib9","series-title":"Inflamm. Chronic Disord. Secret Connect","first-page":"9","article-title":"Inflammation and alzheimer\u2019s disease","author":"Chauhan","year":"2023"},{"key":"10.1016\/j.prp.2025.156109_bib10","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/nutrit\/nuw023","article-title":"Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease","volume":"74","author":"Pistollato","year":"2016","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.prp.2025.156109_bib11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2174\/1567205014666170505101426","article-title":"Lipid biomarkers in Alzheimer\u2019s disease","volume":"15","author":"Zarrouk","year":"2018","journal-title":"Curr. Alzheimer Res"},{"key":"10.1016\/j.prp.2025.156109_bib12","first-page":"1","article-title":"Unveiling the involvement of herpes simplex virus-1 in Alzheimer\u2019s disease: Possible mechanisms and therapeutic implications","volume":"12","author":"Chauhan","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.prp.2025.156109_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1752-0509-6-52","article-title":"AlzPathway: A comprehensive map of signaling pathways of Alzheimer\u2019s disease","volume":"6","author":"Mizuno","year":"2012","journal-title":"BMC Syst. Biol."},{"key":"10.1016\/j.prp.2025.156109_bib14","first-page":"268","article-title":"Analysis of technological developments in the treatment of Alzheimer\u2019s disease through patent documents","volume":"7","author":"Carvalho","year":"2015","journal-title":"Intell. Inf. Manag"},{"key":"10.1016\/j.prp.2025.156109_bib15","doi-asserted-by":"crossref","first-page":"12924","DOI":"10.3390\/ijms232112924","article-title":"Amyloid beta in aging and Alzheimer\u2019s disease","volume":"23","author":"Sehar","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.prp.2025.156109_bib16","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.febslet.2013.05.010","article-title":"The amyloid precursor protein: A biochemical enigma in brain development, function and disease","volume":"587","author":"Nalivaeva","year":"2013","journal-title":"FEBS Lett."},{"key":"10.1016\/j.prp.2025.156109_bib17","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.prp.2025.156109_bib18","first-page":"1","article-title":"Amyloid \u03b2-based therapy for Alzheimer\u2019s disease: challenges, successes and future","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.prp.2025.156109_bib19","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1126\/science.1168979","article-title":"A recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis","volume":"323","author":"Di Fede","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.prp.2025.156109_bib20","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1096\/fj.201700359","article-title":"Amyloid precursor protein and endosomal-lysosomal dysfunction in Alzheimer\u2019s disease: inseparable partners in a multifactorial disease","volume":"31","author":"Nixon","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.prp.2025.156109_bib21","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00401-013-1152-3","article-title":"The Alzheimer\u2019s \u03b2-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques","volume":"126","author":"Kandalepas","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.prp.2025.156109_bib22","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13195-020-00686-3","article-title":"\u03b2-Secretase1 biological markers for Alzheimer\u2019s disease: state-of-art of validation and qualification","volume":"12","author":"Hampel","year":"2020","journal-title":"Alzheimer\u2019S. Res Ther."},{"key":"10.1016\/j.prp.2025.156109_bib23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00401-016-1558-9","article-title":"Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased A\u03b2 generation in Alzheimer\u2019s disease","volume":"132","author":"Sadleir","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.prp.2025.156109_bib24","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature14864","article-title":"\u03b7-Secretase processing of APP inhibits neuronal activity in the hippocampus","volume":"526","author":"Willem","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.prp.2025.156109_bib25","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.neuron.2013.09.031","article-title":"ADAM10 prodomain mutations cause late-onset Alzheimer\u2019s disease: not just the latest FAD","volume":"80","author":"Vassar","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.prp.2025.156109_bib26","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1038\/emboj.2010.167","article-title":"ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons","volume":"29","author":"Kuhn","year":"2010","journal-title":"EMBO J."},{"key":"10.1016\/j.prp.2025.156109_bib27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrneurol.2009.218","article-title":"The secretases: enzymes with therapeutic potential in Alzheimer disease","volume":"6","author":"De Strooper","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.prp.2025.156109_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0301-0082(03)00089-3","article-title":"Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory","volume":"70","author":"Turner","year":"2003","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.prp.2025.156109_bib29","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1097\/00001756-199909290-00017","article-title":"Primary cultures of neuronal and non-neuronal rat brain cells secrete similar proportions of amyloid \u03b2 peptides ending at A\u03b240 and A\u03b242","volume":"10","author":"Fukumoto","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.prp.2025.156109_bib30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fneur.2013.00079","article-title":"Amyloid-\u03b2 peptides and tau protein as biomarkers in cerebrospinal and interstitial fluid following traumatic brain injury: A review of rxperimental and clinical Sstudies","volume":"4","author":"Tsitsopoulos","year":"2013","journal-title":"Front Neurol."},{"key":"10.1016\/j.prp.2025.156109_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12684","article-title":"Amyloid Beta monomers regulate cyclic adenosine monophosphate response element binding protein functions by activating type-1 insulin-like growth factor receptors in neuronal cells","volume":"17","author":"Zimbone","year":"2018","journal-title":"Aging Cell"},{"key":"10.1016\/j.prp.2025.156109_bib32","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/s41591-019-0375-9","article-title":"Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer\u2019s disease","volume":"25","author":"Moreno-Jim\u00e9nez","year":"2019","journal-title":"Nat. Med"},{"key":"10.1016\/j.prp.2025.156109_bib33","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00401-018-1918-8","article-title":"Questions concerning the role of amyloid-\u03b2 in the definition, aetiology and diagnosis of Alzheimer\u2019s disease","volume":"136","author":"Morris","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.prp.2025.156109_bib34","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer\u2019s disease","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.prp.2025.156109_bib35","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0344-0338(11)81194-5","article-title":"What\u2019s new in the pathology of neuronal cytoskeleton: The significance of neurofibrillary tangles","volume":"188","author":"Dustin","year":"1992","journal-title":"Pathol. Res Pr."},{"key":"10.1016\/j.prp.2025.156109_bib36","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.4103\/0366-6999.235112","article-title":"Research progress in the pathogenesis of Alzheimer\u2019s disease","volume":"131","author":"Chen","year":"2018","journal-title":"Chin. Med J. (Engl. )"},{"key":"10.1016\/j.prp.2025.156109_bib37","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.trsl.2022.10.009","article-title":"Targeting caspase-2 interactions with tau in Alzheimer\u2019s disease and related dementias","volume":"254","author":"Pockes","year":"2023","journal-title":"Transl. Res"},{"key":"10.1016\/j.prp.2025.156109_bib38","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejmech.2017.07.070","article-title":"Tau protein aggregation in Alzheimer\u2019s disease: An attractive target for the development of novel therapeutic agents","volume":"139","author":"Jouanne","year":"2017","journal-title":"Eur. J. Med Chem."},{"key":"10.1016\/j.prp.2025.156109_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.00155","article-title":"Understanding the pathophysiological actions of tau oligomers: A critical review of current electrophysiological approaches","volume":"13","author":"Hill","year":"2020","journal-title":"Front Mol. Neurosci."},{"key":"10.1016\/j.prp.2025.156109_bib40","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1001\/archneur.1993.00540040011008","article-title":"Neuropathological indexes of Alzheimer\u2019s disease in demented and mondemented persons aged 80 years and older","volume":"50","author":"Berg","year":"1993","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.prp.2025.156109_bib41","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jalz.2015.06.1895","article-title":"\u03b2-Amyloid pathogenesis: Chemical properties versus cellular levels","volume":"12","author":"Tiwari","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.prp.2025.156109_bib42","doi-asserted-by":"crossref","first-page":"926","DOI":"10.2174\/1570159X15666170116143743","article-title":"The amyloid cascade hypothesis in alzheimer\u2019s disease: It\u2019s time to change our mind","volume":"15","author":"Ricciarelli","year":"2017","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.prp.2025.156109_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2019.00034","article-title":"Pathological tau from Alzheimer\u2019s brain induces site-specific hyperphosphorylation and SDS- and reducing agent-resistant aggregation of tau in vivo","volume":"11","author":"Miao","year":"2019","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.prp.2025.156109_bib44","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00401-018-1932-x","article-title":"Current state of Alzheimer\u2019s fluid biomarkers","volume":"136","author":"Molinuevo","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.prp.2025.156109_bib45","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3233\/JAD-160448","article-title":"Non-phosphorylated tau as a potential biomarker of Alzheimer\u2019s Disease: Analytical and diagnostic characterization","volume":"55","author":"Lewczuk","year":"2017","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.prp.2025.156109_bib46","doi-asserted-by":"crossref","first-page":"19702","DOI":"10.1074\/jbc.270.34.19702","article-title":"Amyloid beta-protein inhibits ubiquitin-dependent protein degradation in vitro","volume":"270","author":"Gregori","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2025.156109_bib47","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0531-5565(02)00151-1","article-title":"Aging and the human neocortex","volume":"38","author":"Pakkenberg","year":"2003","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.prp.2025.156109_bib48","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1007\/s00018-007-7220-x","article-title":"Tauopathies","volume":"64","author":"Hern\u00e1ndez","year":"2007","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.prp.2025.156109_bib49","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1172\/JCI24761","article-title":"The genetic epidemiology of neurodegenerative disease","volume":"115","author":"Bertram","year":"2005","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.prp.2025.156109_bib50","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jalz.2016.01.012","article-title":"Molecular genetics of early-onset Alzheimer\u2019s disease revisited","volume":"12","author":"Cacace","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.prp.2025.156109_bib51","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/archneurol.2011.221","article-title":"Autosomal recessive causes likely in early-onset Alzheimer disease","volume":"69","author":"Wingo","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.prp.2025.156109_bib52","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1001\/archneur.55.3.294","article-title":"The genetics of Alzheimer disease: Current status and future prospects","volume":"55","author":"Blacker","year":"1998","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.prp.2025.156109_bib53","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.arcmed.2012.10.017","article-title":"Genetics of Alzheimer\u2019s disease","volume":"43","author":"Alonso Vilatela","year":"2012","journal-title":"Arch. Med Res"},{"key":"10.1016\/j.prp.2025.156109_bib54","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/349704a0","article-title":"Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer\u2019s disease","volume":"349","author":"Goate","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.prp.2025.156109_bib55","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/375754a0","article-title":"Cloning of a gene bearing missense mutations in early-onset familial Alzheimer\u2019s disease","volume":"375","author":"Sherrington","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.prp.2025.156109_bib56","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/376775a0","article-title":"Familial Alzheimer\u2019s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer\u2019s disease type 3 gene","volume":"376","author":"Rogaev","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.prp.2025.156109_bib57","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/2047-9158-1-18","article-title":"Advances in the pathogenesis of Alzheimer\u2019s disease: a re-evaluation of amyloid cascade hypothesis","volume":"1","author":"Dong","year":"2012","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.prp.2025.156109_bib58","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","article-title":"Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.prp.2025.156109_bib59","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng0694-180","article-title":"Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease","volume":"7","author":"Corder","year":"1994","journal-title":"Nat. Genet"},{"key":"10.1016\/j.prp.2025.156109_bib60","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.neuron.2014.01.045","article-title":"ApoE and A\u03b2 in Alzheimer\u2019s disease: accidental encounters or partners?","volume":"81","author":"Kanekiyo","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.prp.2025.156109_bib61","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.29595","article-title":"Clearance of beta-amyloid is facilitated by apolipoprotein E and circulating highdensity lipoproteins in bioengineered human vessels","volume":"6","author":"Robert","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.prp.2025.156109_bib62","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.conb.2019.11.024","article-title":"Genetics of Alzheimer\u2019s disease: where we are, and where we are going","volume":"61","author":"Bellenguez","year":"2020","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.prp.2025.156109_bib63","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","article-title":"New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias","volume":"54","author":"Bellenguez","year":"2022","journal-title":"Nat. Genet"},{"key":"10.1016\/j.prp.2025.156109_bib64","doi-asserted-by":"crossref","first-page":"13833","DOI":"10.1074\/jbc.M610146200","article-title":"Amyloid precursor protein and Presenilin1 interact with the adaptor GRB2 and modulate ERK 1,2 signaling","volume":"282","author":"Nizzari","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2025.156109_bib65","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ng.440","article-title":"Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease","volume":"41","author":"Harold","year":"2009","journal-title":"Nat. Genet"},{"key":"10.1016\/j.prp.2025.156109_bib66","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","article-title":"Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease","volume":"41","author":"Lambert","year":"2009","journal-title":"Nat. Genet"},{"key":"10.1016\/j.prp.2025.156109_bib67","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ng.801","article-title":"Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer\u2019s disease","volume":"43","author":"Naj","year":"2011","journal-title":"Nat. Genet"},{"key":"10.1016\/j.prp.2025.156109_bib68","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.neuron.2009.11.013","article-title":"Overexpression of low-density lipoprotein receptor in the brain markedly inhibits amyloid deposition and increases extracellular A beta clearance","volume":"64","author":"Kim","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.prp.2025.156109_bib69","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1017\/S1092852900014164","article-title":"The interplay of neurotransmitters in Alzheimer\u2019s disease","volume":"10","author":"Francis","year":"2005","journal-title":"CNS Spectr."},{"key":"10.1016\/j.prp.2025.156109_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a016824","article-title":"Synaptic signaling in learning and memory","volume":"8","author":"Kennedy","year":"2016","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.prp.2025.156109_bib71","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/jpet.102.041616","article-title":"The cholinergic hypothesis of age and Alzheimer\u2019s disease-related cognitive deficits: recent challenges and their implications for novel drug development","volume":"306","author":"Terry","year":"2003","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.prp.2025.156109_bib72","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.3390\/molecules27061816","article-title":"Role of cholinergic signaling in Alzheimer\u2019s disease","volume":"27","author":"Chen","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.prp.2025.156109_bib73","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0306-4522(86)90242-3","article-title":"Alzheimer plaques and cortical cholinergic innervation","volume":"17","author":"Mesulam","year":"1986","journal-title":"Neuroscience"},{"key":"10.1016\/j.prp.2025.156109_bib74","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/sj.mp.4000878","article-title":"Short- and long-term effect of acetylcholinesterase inhibition on the expression and metabolism of the amyloid precursor protein","volume":"6","author":"Racchi","year":"2001","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.prp.2025.156109_bib75","doi-asserted-by":"crossref","first-page":"10447","DOI":"10.1021\/bi0101392","article-title":"A structural motif of acetylcholinesterase that promotes amyloid \u03b2-peptide fibril formation","volume":"40","author":"De Ferrari","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.prp.2025.156109_bib76","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0006-8993(02)03262-6","article-title":"Impairment of cholinergic neurotransmission in adult and aged transgenic Tg2576 mouse brain expressing the Swedish mutation of human \u03b2-amyloid precursor protein","volume":"953","author":"Apelt","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.prp.2025.156109_bib77","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/archneur.1997.00550160091022","article-title":"Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease","volume":"54","author":"Bodick","year":"1997","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.prp.2025.156109_bib78","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1471-4159.1978.tb07029.x","article-title":"Sodium-dependent, high affinity choline uptake","volume":"30","author":"Kuhar","year":"1978","journal-title":"J. Neurochem."},{"key":"10.1016\/j.prp.2025.156109_bib79","doi-asserted-by":"crossref","first-page":"14140","DOI":"10.1073\/pnas.0704070104","article-title":"Amyolid precursor protein mediates presynaptic localization and activity of the high-affinity choline transporter","volume":"104","author":"Wang","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.prp.2025.156109_bib80","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/00005072-200606000-00007","article-title":"Differential expression of synaptic proteins in the frontal and temporal cortex of elderly subjects with mild cognitive impairment","volume":"65","author":"Counts","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.prp.2025.156109_bib81","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/aps.2009.24","article-title":"Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases","volume":"30","author":"Dong","year":"2009","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.prp.2025.156109_bib82","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.neuint.2004.03.007","article-title":"Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer\u2019s disease","volume":"45","author":"Hynd","year":"2004","journal-title":"Neurochem. Int"},{"key":"10.1016\/j.prp.2025.156109_bib83","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10522-020-09860-4","article-title":"Alzheimer\u2019s disease: targeting the glutamatergic system","volume":"21","author":"Conway","year":"2020","journal-title":"Biogerontology"},{"key":"10.1016\/j.prp.2025.156109_bib84","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1046\/j.1460-9568.2000.00189.x","article-title":"Blockade of the NMDA receptor increases developmental apoptotic elimination of granule neurons and activates caspases in the rat cerebellum","volume":"12","author":"Monti","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.prp.2025.156109_bib85","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nrn2911","article-title":"Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders","volume":"11","author":"Hardingham","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.prp.2025.156109_bib86","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.neuron.2014.03.030","article-title":"Extrasynaptic NMDA receptor involvement in central nervous system disorders","volume":"82","author":"Parsons","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.prp.2025.156109_bib87","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0896-6273(88)90162-6","article-title":"Glutamate neurotoxicity and diseases of the nervous system","volume":"1","author":"Choi","year":"1988","journal-title":"Neuron"},{"key":"10.1016\/j.prp.2025.156109_bib88","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJM199403033300907","article-title":"Excitatory amino acids as a final common pathway for neurologic disorders","volume":"330","author":"Epstein","year":"1994","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.prp.2025.156109_bib89","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/0269881118754680","article-title":"Excitotoxicity in the pathogenesis of neurological and psychiatric disorders: Therapeutic implications","volume":"32","author":"Olloquequi","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.prp.2025.156109_bib90","doi-asserted-by":"crossref","first-page":"5911","DOI":"10.3390\/ijms22115911","article-title":"When good kinases go rogue: GSK3, p38 MAPK and CDKs as therapeutic targets for Alzheimer\u2019s and Huntington\u2019s disease","volume":"22","author":"D\u2019mello","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.prp.2025.156109_bib91","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/ana.410400512","article-title":"Deficient glutamate transport is associated with neurodegeneration in Alzheimer\u2019s disease","volume":"40","author":"Masliah","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.prp.2025.156109_bib92","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/00005072-199708000-00008","article-title":"Glutamate transporter alterations in Alzheimer disease are possibly associated with abnormal APP expression","volume":"56","author":"Li","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.prp.2025.156109_bib93","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1471-4159.2006.03935.x","article-title":"Down-regulation of vesicular glutamate transporters precedes cell loss and pathology in Alzheimer\u2019s disease","volume":"98","author":"Kirvell","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.prp.2025.156109_bib94","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/jnr.490410416","article-title":"beta-Amyloid peptide fragment 25-35 potentiates the calcium-dependent release of excitatory amino acids from depolarized hippocampal slices","volume":"41","author":"Arias","year":"1995","journal-title":"J. Neurosci. Res"},{"key":"10.1016\/j.prp.2025.156109_bib95","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.nbd.2003.12.006","article-title":"\u03b2-amyloid25-35 inhibits glutamate uptake in cultured neurons and astrocytes: Modulation of uptake as a survival mechanism","volume":"15","author":"Fern\u00e1ndez-Tom\u00e9","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.prp.2025.156109_bib96","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3389\/fpsyt.2018.00561","article-title":"Elevated glutamate and glutamine levels in the cerebrospinal fluid of patients with probable Alzheimer\u2019s disease and depression","volume":"9","author":"Reis","year":"2018","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.prp.2025.156109_bib97","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.expneurol.2007.10.008","article-title":"Amyloid beta peptides and glutamatergic synaptic dysregulation","volume":"210","author":"Parameshwaran","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.prp.2025.156109_bib98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1041610219001807","article-title":"Decreased glutamine and glutamate: an early biomarker of neurodegeneration","volume":"33","author":"Zeydan","year":"2021","journal-title":"Int Psychogeriatr."},{"key":"10.1016\/j.prp.2025.156109_bib99","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.semcdb.2022.03.013","article-title":"Impairments of glutamatergic synaptic transmission in Alzheimer\u2019s disease","volume":"139","author":"Zott","year":"2023","journal-title":"Semin Cell Dev. Biol."},{"key":"10.1016\/j.prp.2025.156109_bib100","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.3233\/JAD-190773","article-title":"Reduced hippocampal glutamate and posterior cingulate n-acetyl aspartate in mild cognitive impairment and Alzheimer\u2019s disease is associated with episodic memory performance and white matter integrity in the cingulum: A pilot study","volume":"73","author":"Wong","year":"2020","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.prp.2025.156109_bib101","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.bbadis.2013.09.010","article-title":"The Alzheimer\u2019s disease mitochondrial cascade hypothesis: progress and perspectives","volume":"1842","author":"Swerdlow","year":"2014","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.prp.2025.156109_bib102","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.pnpbp.2004.12.007","article-title":"Mitochondrial aging and dysfunction in Alzheimer\u2019s disease","volume":"29","author":"Sullivan","year":"2005","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.prp.2025.156109_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120855","article-title":"Redefining oxidative stress in Alzheimer\u2019s disease: Targeting platelet reactive oxygen species for novel therapeutic options","volume":"306","author":"Beura","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2025.156109_bib104","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0005-2728(98)00114-5","article-title":"Mitochondrial dysfunction in neurodegenerative diseases","volume":"1366","author":"Beal","year":"1998","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.prp.2025.156109_bib105","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.neuropharm.2010.04.005","article-title":"Oxidative stress in Alzheimer disease: a possibility for prevention","volume":"59","author":"Bonda","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.prp.2025.156109_bib106","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1523\/JNEUROSCI.21-09-03017.2001","article-title":"Mitochondrial abnormalities in Alzheimer\u2019s disease","volume":"21","author":"Hirai","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.prp.2025.156109_bib107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-0173(98)00046-0","article-title":"An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration","volume":"29","author":"Cassarino","year":"1999","journal-title":"Brain Res Brain Res Rev."},{"key":"10.1016\/j.prp.2025.156109_bib108","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.freeradbiomed.2022.09.032","article-title":"Altered glucose metabolism in Alzheimer\u2019s disease: Role of mitochondrial dysfunction and oxidative stress","volume":"193","author":"Dewanjee","year":"2022","journal-title":"Free Radic. Biol. Med"},{"key":"10.1016\/j.prp.2025.156109_bib109","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.neuint.2007.02.008","article-title":"The mitochondrial permeability transition in neurologic disease","volume":"50","author":"Norenberg","year":"2007","journal-title":"Neurochem. Int"},{"key":"10.1016\/j.prp.2025.156109_bib110","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.neurobiolaging.2007.12.005","article-title":"Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice","volume":"30","author":"Hauptmann","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.prp.2025.156109_bib111","doi-asserted-by":"crossref","first-page":"14670","DOI":"10.1073\/pnas.0903563106","article-title":"Mitochondrial bioenergetic deficit precedes Alzheimer\u2019s pathology in female mouse model of Alzheimer\u2019s disease","volume":"106","author":"Yao","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.prp.2025.156109_bib112","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1093\/hmg\/ddab363","article-title":"Mitochondrial oxidative stress contributes to the pathological aggregation and accumulation of tau oligomers in Alzheimer\u2019s disease","volume":"31","author":"Du","year":"2022","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.prp.2025.156109_bib113","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1083\/jcb.200108057","article-title":"Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress","volume":"156","author":"Stamer","year":"2002","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.prp.2025.156109_bib114","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1172\/JCI28769","article-title":"Oxidative stress mediates tau-induced neurodegeneration in Drosophila","volume":"117","author":"Dias-Santagata","year":"2007","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.prp.2025.156109_bib115","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1460-9568.2006.04986.x","article-title":"Expression of a truncated tau protein induces oxidative stress in a rodent model of tauopathy","volume":"24","author":"Cente","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.prp.2025.156109_bib116","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3233\/JAD-2009-1107","article-title":"Expression of a truncated human tau protein induces aqueous-phase free radicals in a rat model of tauopathy: Implications for targeted antioxidative therapy","volume":"17","author":"Cente","year":"2009","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.prp.2025.156109_bib117","doi-asserted-by":"crossref","first-page":"14203","DOI":"10.1021\/bi001876l","article-title":"Oxidative regulation of fatty acid-induced tau polymerization","volume":"39","author":"Gamblin","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.prp.2025.156109_bib118","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1371\/journal.pone.0000536","article-title":"Mitochondrial oxidative stress causes hyperphosphorylation of tau","volume":"2","author":"Melov","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2025.156109_bib119","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0014-5793(97)00483-3","article-title":"Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases","volume":"409","author":"Goedert","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.prp.2025.156109_bib120","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s007020070021","article-title":"Apoptosis and Alzheimer\u2019s disease","volume":"107","author":"Behl","year":"2000","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.prp.2025.156109_bib121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0092-8674(00)00003-9","article-title":"Apoptotic pathways: paper wraps stone blunts scissors","volume":"102","author":"Green","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.prp.2025.156109_bib122","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0092-8674(00)00187-2","article-title":"BH3-Only proteins-essential initiators of apoptotic cell death","volume":"103","author":"Huang","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.prp.2025.156109_bib123","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/sj.cdd.4400998","article-title":"Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins","volume":"9","author":"Puthalakath","year":"2002","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.prp.2025.156109_bib124","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.immuni.2009.01.001","article-title":"The many roles of FAS receptor signaling in the immune system","volume":"30","author":"Strasser","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.prp.2025.156109_bib125","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1038\/sj.onc.1209608","article-title":"Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy","volume":"25","author":"Fulda","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2025.156109_bib126","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1056\/NEJMra022366","article-title":"Apoptosis and caspases in neurodegenerative diseases","volume":"348","author":"Friedlander","year":"2003","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.prp.2025.156109_bib127","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1172\/JCI200420640","article-title":"Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology","volume":"114","author":"Rissman","year":"2004","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.prp.2025.156109_bib128","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0092-8674(00)80748-5","article-title":"Involvement of caspases in proteolytic cleavage of Alzheimer\u2019s amyloid-\u03b2 precursor protein and amyloidogenic A\u03b2 peptide formation","volume":"97","author":"Gervais","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.prp.2025.156109_bib129","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1523\/JNEUROSCI.22-10-03963.2002","article-title":"\u03b2-amyloid-induced synthesis of the ganglioside Gd3 is a requisite for cell cycle reactivation and poptoasis in neurons","volume":"22","author":"Copani","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.prp.2025.156109_bib130","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/sj.cdd.4401378","article-title":"Coupling endoplasmic reticulum stress to the cell death program","volume":"11","author":"Rao","year":"2004","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.prp.2025.156109_bib131","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/sj.cdd.4401778","article-title":"ER stress and neurodegenerative diseases","volume":"13","author":"Lindholm","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.prp.2025.156109_bib132","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1083\/jcb.200310015","article-title":"Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and A\u03b2-induced cell death","volume":"165","author":"Hitomi","year":"2004","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.prp.2025.156109_bib133","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jchemneu.2003.12.004","article-title":"Induction of neuronal death by ER stress in Alzheimer\u2019s disease","volume":"28","author":"Katayama","year":"2004","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.prp.2025.156109_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106301","article-title":"The metal ion hypothesis of Alzheimer\u2019s disease and the anti-neuroinflammatory effect of metal chelators","volume":"131","author":"Chen","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.prp.2025.156109_bib135","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-510X(98)00092-6","article-title":"Copper, iron and zinc in Alzheimer\u2019s disease senile plaques","volume":"158","author":"Lovell","year":"1998","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.prp.2025.156109_bib136","doi-asserted-by":"crossref","first-page":"20466","DOI":"10.1074\/jbc.M100175200","article-title":"Alzheimer\u2019s disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits","volume":"276","author":"Curtain","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2025.156109_bib137","doi-asserted-by":"crossref","first-page":"RC10","DOI":"10.1523\/JNEUROSCI.19-11-j0002.1999","article-title":"Histochemically reactive zinc in plaques of the Swedish mutant beta-amyloid precursor protein transgenic mice","volume":"19","author":"Lee","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.prp.2025.156109_bib138","doi-asserted-by":"crossref","first-page":"4508","DOI":"10.1021\/acsomega.2c06939","article-title":"Role of metal cations of copper, iron, and aluminum and multifunctional ligands in Alzheimer\u2019s disease: Experimental and computational insights","volume":"8","author":"Puentes-D\u00edaz","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.prp.2025.156109_bib139","doi-asserted-by":"crossref","first-page":"12817","DOI":"10.1074\/jbc.273.21.12817","article-title":"Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis","volume":"273","author":"Atwood","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2025.156109_bib140","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1046\/j.1471-4159.2000.0751219.x","article-title":"Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42","volume":"75","author":"Atwood","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.prp.2025.156109_bib141","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1212\/01.WNL.0000070185.02546.5D","article-title":"Enhanced brain levels of 8,12-iso-iPF2\u03b1-VI differentiate AD from frontotemporal dementia","volume":"61","author":"Yao","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.prp.2025.156109_bib142","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.freeradbiomed.2010.10.707","article-title":"\u03b2-Amyloid peptide increases levels of iron content and oxidative stress in human cell and Caenorhabditis elegans models of Alzheimer disease","volume":"50","author":"Wan","year":"2011","journal-title":"Free Radic. Biol. Med"},{"key":"10.1016\/j.prp.2025.156109_bib143","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1096\/fj.09-135749","article-title":"Divalent metal transporter 1 is involved in amyloid precursor protein processing and Abeta generation","volume":"23","author":"Zheng","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.prp.2025.156109_bib144","doi-asserted-by":"crossref","first-page":"45518","DOI":"10.1074\/jbc.M207435200","article-title":"An iron-responsive element type II in the 5\u2019-untranslated region of the Alzheimer\u2019s amyloid precursor protein transcript","volume":"277","author":"Rogers","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2025.156109_bib145","doi-asserted-by":"crossref","first-page":"44670","DOI":"10.1074\/jbc.M204379200","article-title":"Overexpression of Alzheimer\u2019s disease amyloid-beta opposes the age-dependent elevations of brain copper and iron","volume":"277","author":"Maynard","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2025.156109_bib146","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0165-0173(02)00219-9","article-title":"Zinc takes the center stage: its paradoxical role in Alzheimer\u2019s disease","volume":"41","author":"Cuajungco","year":"2003","journal-title":"Brain Res Rev."},{"key":"10.1016\/j.prp.2025.156109_bib147","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.neurobiolaging.2008.02.018","article-title":"Altered expression and distribution of zinc transporters in APP\/PS1 transgenic mouse brain","volume":"31","author":"Zhang","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.prp.2025.156109_bib148","first-page":"17401","article-title":"Structure of the Alzheimer\u2019s disease amyloid precursor protein copper binding domain","volume":"278","author":"Barnham","year":"2003","journal-title":"A Regul. Neuron Copp. Homeost. J. Biol. Chem."},{"key":"10.1016\/j.prp.2025.156109_bib149","doi-asserted-by":"crossref","first-page":"7024","DOI":"10.1021\/bi0002479","article-title":"Metal binding modes of Alzheimer\u2019s amyloid beta-peptide in insoluble aggregates and soluble complexes","volume":"39","author":"Miura","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.prp.2025.156109_bib150","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.neurobiolaging.2007.10.012","article-title":"Zinc and copper modulate Alzheimer A\u03b2 levels in human cerebrospinal fluid","volume":"30","author":"Strozyk","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.prp.2025.156109_bib151","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22063101","article-title":"Cellular and molecular mechanisms mediating methylmercury neurotoxicity and neuroinflammation","volume":"22","author":"Novo","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.prp.2025.156109_bib152","article-title":"Methylmercury impact on adult neurogenesis: is the worst yet to come from recent Brazilian environmental disasters?","volume":"15","author":"Raposo R da","year":"2023","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.prp.2025.156109_bib153","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cotox.2021.03.006","article-title":"Heavy metals and adult neurogenesis","volume":"26","author":"Wang","year":"2021","journal-title":"Curr. Opin. Toxicol."},{"key":"10.1016\/j.prp.2025.156109_bib154","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1471-4159.2000.0740231.x","article-title":"Mercury induces cell cytotoxicity and oxidative stress and increases beta-amyloid secretion and tau phosphorylation in SHSY5Y neuroblastoma cells","volume":"74","author":"Olivieri","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.prp.2025.156109_bib155","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1096\/fj.10-174078","article-title":"Mercury is a direct and potent \u03b3-secretase inhibitor affecting Notch processing and development in Drosophila","volume":"25","author":"Alattia","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.prp.2025.156109_bib156","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3390\/biom10010044","article-title":"Mercury and alzheimer\u2019s disease: Hg(II) ions display specific binding to the amyloid-\u03b2 peptide and hinder its fibrillization","volume":"10","author":"Wallin","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.prp.2025.156109_bib157","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.jinorgbio.2009.07.023","article-title":"Demonstration of aluminum in amyloid fibers in the cores of senile plaques in the brains of patients with Alzheimer\u2019s disease","volume":"103","author":"Yumoto","year":"2009","journal-title":"J. Inorg. Biochem"},{"key":"10.1016\/j.prp.2025.156109_bib158","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s12640-011-9246-y","article-title":"Higher aluminum concentration in Alzheimer\u2019s disease after Box-Cox data transformation","volume":"20","author":"Rusina","year":"2011","journal-title":"Neurotox. Res"},{"key":"10.1016\/j.prp.2025.156109_bib159","first-page":"445","article-title":"Impact of sub-chronic aluminium-maltolate exposure on catabolism of amyloid precursor protein in rats","volume":"26","author":"Liang","year":"2013","journal-title":"Biomed. Environ. Sci."},{"key":"10.1016\/j.prp.2025.156109_bib160","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.neulet.2008.05.070","article-title":"Exposure to metal ions regulates mRNA levels of APP and BACE1 in PC12 cells: blockage by curcumin","volume":"440","author":"Lin","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.prp.2025.156109_bib161","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.taap.2013.09.012","article-title":"Aluminium induced oxidative stress results in decreased mitochondrial biogenesis via modulation of PGC-1\u03b1 expression","volume":"273","author":"Sharma","year":"2013","journal-title":"Toxicol. Appl. Pharm."},{"key":"10.1016\/j.prp.2025.156109_bib162","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ijdevneu.2011.03.004","article-title":"Arsenic affects expression and processing of amyloid precursor protein (APP) in primary neuronal cells overexpressing the Swedish mutation of human APP","volume":"29","author":"Zaraz\u00faa","year":"2011","journal-title":"Int J. Dev. Neurosci."},{"key":"10.1016\/j.prp.2025.156109_bib163","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.3390\/cells12212537","article-title":"Mechanisms associated with cognitive and behavioral impairment induced by arsenic exposure","volume":"12","author":"V\u00e1zquez Cervantes","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.prp.2025.156109_bib164","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2131\/jts.44.777","article-title":"Alterations of NMDA and AMPA receptors and their signaling apparatus in the hippocampus of mouse offspring induced by developmental arsenite exposure","volume":"44","author":"Zhao","year":"2019","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.prp.2025.156109_bib165","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3390\/toxics9090198","article-title":"Molecular mechanisms of environmental metal neurotoxicity: A focus on the interactions of metals with synapse structure and function","volume":"9","author":"Carmona","year":"2021","journal-title":"Toxics"},{"key":"10.1016\/j.prp.2025.156109_bib166","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1021\/acsbiomedchemau.3c00066","article-title":"Genetic targets and applications of iron chelators for neurodegeneration with brain iron accumulation","volume":"4","author":"Marupudi","year":"2024","journal-title":"ACS Bio Med Chem. Au"},{"key":"10.1016\/j.prp.2025.156109_bib167","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10753-022-01721-1","article-title":"Neuroinflammation in Alzheimer\u2019s disease: Current progress in molecular signaling and therapeutics","volume":"46","author":"Thakur","year":"2023","journal-title":"Inflammation"},{"key":"10.1016\/j.prp.2025.156109_bib168","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.arr.2008.07.002","article-title":"Molecular inflammation: Underpinnings of aging and age-related diseases","volume":"8","author":"Chung","year":"2009","journal-title":"Ageing Res Rev."},{"key":"10.1016\/j.prp.2025.156109_bib169","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-022-02565-0","article-title":"Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer\u2019s disease","volume":"19","author":"Singh","year":"2022","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.prp.2025.156109_bib170","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cnr.2006.09.004","article-title":"The cellular response in neuroinflammation: The role of leukocytes, microglia and astrocytes in neuronal death and survival","volume":"6","author":"Carson","year":"2006","journal-title":"Clin. Neurosci. Res"},{"key":"10.1016\/j.prp.2025.156109_bib171","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.nurt.2010.05.014","article-title":"Microglial activation and chronic neurodegeneration","volume":"7","author":"Lull","year":"2010","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.prp.2025.156109_bib172","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neures.2013.10.004","article-title":"Neuroinflammation: the role and consequences","volume":"79","author":"Lyman","year":"2014","journal-title":"Neurosci. Res"},{"key":"10.1016\/j.prp.2025.156109_bib173","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3389\/fneur.2018.00797","article-title":"Elucidating the interactive roles of glia in Alzheimer\u2019s disease using established and newly developed experimental models","volume":"9","author":"Chun","year":"2018","journal-title":"Front Neurol."},{"issue":"9","key":"10.1016\/j.prp.2025.156109_bib174","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1172\/JCI90606","article-title":"Microglia in Alzheimer\u2019s disease","volume":"127","author":"Sarlus","year":"2017","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.prp.2025.156109_bib175","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1523\/JNEUROSCI.4814-07.2008","article-title":"Dynamics of the microglial\/amyloid interaction indicate a role in plaque maintenance","volume":"28","author":"Bolmont","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.prp.2025.156109_bib176","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3389\/fnagi.2018.00140","article-title":"Microglia in Alzheimer\u2019s disease: Activated, dysfunctional or degenerative","volume":"10","author":"Navarro","year":"2018","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.prp.2025.156109_bib177","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s10787-019-00580-x","article-title":"Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer\u2019s disease","volume":"27","author":"Kaur","year":"2019","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.prp.2025.156109_bib178","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1523\/JNEUROSCI.2594-19.2020","article-title":"The dual role of microglia in the progression of Alzheimer\u2019s disease","volume":"40","author":"Onuska","year":"2020","journal-title":"J. Neurosci."},{"key":"10.1016\/j.prp.2025.156109_bib179","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40659-022-00404-3","article-title":"Inflammation context in Alzheimer\u2019s disease, a relationship intricate to define","volume":"55","author":"Novoa","year":"2022","journal-title":"Biol. Res"},{"key":"10.1016\/j.prp.2025.156109_bib180","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.neurobiolaging.2008.05.015","article-title":"Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain","volume":"31","author":"Simpson","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.prp.2025.156109_bib181","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.170228","article-title":"The role of astrocytes in amyloid production and Alzheimer\u2019s disease","volume":"7","author":"Frost","year":"2017","journal-title":"Open Biol."},{"key":"10.1016\/j.prp.2025.156109_bib182","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/acel.12521","article-title":"Amyloid \u03b2-induced astrogliosis is mediated by \u03b21-integrin via NADPH oxidase 2 in Alzheimer\u2019s disease","volume":"15","author":"Wyssenbach","year":"2016","journal-title":"Aging Cell"},{"key":"10.1016\/j.prp.2025.156109_bib183","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3389\/fnagi.2020.00148","article-title":"Astrocyte senescence and Alzheimer\u2019s disease: A review","volume":"12","author":"Han","year":"2020","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.prp.2025.156109_bib184","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.nurt.2010.05.017","article-title":"Astrocytes in Alzheimer\u2019s disease","volume":"7","author":"Verkhratsky","year":"2010","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.prp.2025.156109_bib185","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.03.002","article-title":"The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders: Potential targets for neurotherapeutics","volume":"161","author":"Pajarillo","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.prp.2025.156109_bib186","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/pnp.444","article-title":"Evidence for neuroinflammation in Alzheimer\u2019s disease","volume":"20","author":"Walters","year":"2016","journal-title":"Prog. Neurol. Psychiatry"},{"key":"10.1016\/j.prp.2025.156109_bib187","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bbalip.2014.08.011","article-title":"Lipids in the nervous system: from biochemistry and molecular biology to patho-physiology","volume":"1851","author":"Cermenati","year":"2015","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.prp.2025.156109_bib188","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3389\/fphys.2012.00189","article-title":"Lipid rafts and Alzheimer\u2019s disease: Protein-lipid interactions and perturbation of signaling","volume":"3","author":"Hicks","year":"2012","journal-title":"Front Physiol."},{"key":"10.1016\/j.prp.2025.156109_bib189","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nn0403-345","article-title":"Alzheimer\u2019s disease: the cholesterol connection","volume":"6","author":"Puglielli","year":"2003","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.prp.2025.156109_bib190","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.690372","article-title":"Cholesterol and Alzheimer\u2019s disease; From risk genes to pathological effects","volume":"13","author":"Feringa","year":"2021","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.prp.2025.156109_bib191","article-title":"Alzheimer-like brain metabolic and structural features in cholesterol-fed rabbit detected by magnetic resonance imaging","volume":"17","author":"Jin","year":"2018","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.prp.2025.156109_bib192","doi-asserted-by":"crossref","first-page":"12260","DOI":"10.1073\/pnas.92.26.12260","article-title":"Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease","volume":"92","author":"Poirier","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.prp.2025.156109_bib193","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.3390\/biomedicines10071495","article-title":"High-density lipoprotein changes in Alzheimer\u2019s disease are APOE genotype-specific","volume":"10","author":"Hong","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.prp.2025.156109_bib194","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/MOL.0000000000000257","article-title":"HDL-cholesterol and apolipoproteins in relation to dementia","volume":"27","author":"Koch","year":"2016","journal-title":"Curr. Opin. Lipido"},{"key":"10.1016\/j.prp.2025.156109_bib195","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nrn3012","article-title":"Linking lipids to Alzheimer\u2019s disease: cholesterol and beyond","volume":"12","author":"Di Paolo","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.prp.2025.156109_bib196","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3233\/ADR-210299","article-title":"A new hypothesis for Alzheimer\u2019s disease: The lipid invasion model","volume":"6","author":"Rudge","year":"2022","journal-title":"J. Alzheimer\u2019S. Dis. Rep."},{"issue":"2","key":"10.1016\/j.prp.2025.156109_bib197","article-title":"24S-hydroxycholesterol: a marker of brain cholesterol metabolism","volume":"36","author":"L\u00fctjohann","year":"2003","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.prp.2025.156109_bib198","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0022-3956(01)00050-4","article-title":"24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia","volume":"36","author":"Papassotiropoulos","year":"2002","journal-title":"J. Psychiatr. Res"},{"key":"10.1016\/j.prp.2025.156109_bib199","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neulet.2009.06.073","article-title":"Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer\u2019s disease","volume":"462","author":"Solomon","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.prp.2025.156109_bib200","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.nbd.2009.05.005","article-title":"Regulation of the brain isoprenoids farnesyl- and geranylgeranylpyrophosphate is altered in male Alzheimer patients","volume":"35","author":"Eckert","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.prp.2025.156109_bib201","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1080\/15548627.2018.1438807","article-title":"Cholesterol impairs autophagy-mediated clearance of amyloid beta while promoting its secretion","volume":"14","author":"Barbero-Camps","year":"2018","journal-title":"Autophagy"},{"key":"10.1016\/j.prp.2025.156109_bib202","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cca.2016.02.024","article-title":"Imbalanced cholesterol metabolism in Alzheimer\u2019s disease","volume":"456","author":"Xue-Shan","year":"2016","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.prp.2025.156109_bib203","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1212\/WNL.54.12.2356-a","article-title":"The effect of apoE on dementia is not through atherosclerosis: the Rotterdam study","volume":"54","author":"Knittweis","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.prp.2025.156109_bib204","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1001\/archneur.64.1.103","article-title":"Twenty-six-year change in total cholesterol levels and incident dementia: the Honolulu-Asia Aging Study","volume":"64","author":"Stewart","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.prp.2025.156109_bib205","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1212\/01.WNL.0000149519.47454.F2","article-title":"Midlife cardiovascular risk factors and risk of dementia in late life","volume":"64","author":"Whitmer","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.prp.2025.156109_bib206","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.prp.2025.156109_bib207","doi-asserted-by":"crossref","first-page":"1258640","DOI":"10.3389\/fnagi.2023.1258640","article-title":"Blood-brain barrier dysfunction and Alzheimer\u2019s disease: associations, pathogenic mechanisms, and therapeutic potential","volume":"15","author":"Chen","year":"2023","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.prp.2025.156109_bib208","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.695479","article-title":"Relationship between amyloid-\u03b2 deposition and blood\u2013brain barrier dysfunction in Alzheimer\u2019s disease","volume":"15","author":"Wang","year":"2021","journal-title":"Front Cell Neurosci."},{"key":"10.1016\/j.prp.2025.156109_bib209","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.570045","article-title":"Tau protein and its role in blood\u2013brain barrier dysfunction","volume":"13","author":"Michalicova","year":"2020","journal-title":"Front Mol. Neurosci."},{"key":"10.1016\/j.prp.2025.156109_bib210","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","article-title":"Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction","volume":"25","author":"Nation","year":"2019","journal-title":"Nat. Med"},{"key":"10.1016\/j.prp.2025.156109_bib211","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.2967\/jnumed.113.130161","article-title":"Activity of P-glycoprotein, a \u03b2-amyloid transporter at the blood-brain barrier, is compromised in patients with mild Alzheimer disease","volume":"55","author":"Deo","year":"2014","journal-title":"J. Nucl. Med"},{"key":"10.1016\/j.prp.2025.156109_bib212","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.3390\/ijms18091965","article-title":"Blood-brain barrier dysfunction and the pathogenesis of alzheimer\u2019s disease","volume":"18","author":"Yamazaki","year":"2017","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.prp.2025.156109_bib213","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3233\/JAD-180098","article-title":"Role of blood-brain barrier in Alzheimer\u2019s disease","volume":"63","author":"Cai","year":"2018","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.prp.2025.156109_bib214","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/B978-0-12-386986-9.00003-X","article-title":"The blood-brain barrier in Alzheimer\u2019s disease: novel therapeutic targets and nanodrug delivery","volume":"102","author":"Sharma","year":"2012","journal-title":"Int Rev. Neurobiol."},{"key":"10.1016\/j.prp.2025.156109_bib215","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108119","article-title":"Blood-brain barrier leakage in Alzheimer\u2019s disease: From discovery to clinical relevance","volume":"234","author":"Nehra","year":"2022","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.prp.2025.156109_bib216","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1073\/pnas.0709788105","article-title":"Altered morphology and 3D architecture of brain vasculature in a mouse model for Alzheimer\u2019s disease","volume":"105","author":"Meyer","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.prp.2025.156109_bib217","doi-asserted-by":"crossref","first-page":"A197","DOI":"10.1515\/nf-2018-A014","article-title":"The blood brain-barrier and its role in Alzheimer\u2019s disease","volume":"24","author":"Storck","year":"2018","journal-title":"Neuroforum"},{"key":"10.1016\/j.prp.2025.156109_bib218","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nn.3966","article-title":"GLUT1 reductions exacerbate Alzheimer\u2019s disease vasculo-neuronal dysfunction and degeneration","volume":"18","author":"Winkler","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.prp.2025.156109_bib219","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-8-38","article-title":"Blood-brain-barriers in aging and in Alzheimer\u2019s disease","volume":"8","author":"Marques","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.prp.2025.156109_bib220","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuint.2014.05.004","article-title":"Dysfunctional Wnt\/\u03b2-catenin signaling contributes to blood-brain barrier breakdown in Alzheimer\u2019s disease","volume":"75","author":"Liu","year":"2014","journal-title":"Neurochem. Int"},{"key":"10.1016\/j.prp.2025.156109_bib221","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-161141","article-title":"The gut microbiota and Alzheimer\u2019s disease","volume":"58","author":"Jiang","year":"2017","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.prp.2025.156109_bib222","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00632-19","article-title":"Alzheimer\u2019s disease microbiome is associated with dysregulation of the anti-inflammatory P-glycoprotein pathway","volume":"10","author":"Haran","year":"2019","journal-title":"MBio"},{"key":"10.1016\/j.prp.2025.156109_bib223","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118627","article-title":"Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer\u2019s disease","volume":"264","author":"Kesika","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2025.156109_bib224","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.bbr.2012.01.010","article-title":"Prolonged elevation in hippocampal A\u03b2 and cognitive deficits following repeated endotoxin exposure in the mouse","volume":"229","author":"Kahn","year":"2012","journal-title":"Behav. Brain Res"},{"key":"10.1016\/j.prp.2025.156109_bib225","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3233\/JAD-131394","article-title":"Can a bacterial endotoxin be a key factor in the kinetics of amyloid fibril formation?","volume":"39","author":"Asti","year":"2014","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.prp.2025.156109_bib226","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3233\/JAD-160884","article-title":"Alzheimer\u2019s disease histological and behavioral manifestations in transgenic mice correlate with specific gut microbiome state","volume":"56","author":"Shen","year":"2017","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.prp.2025.156109_bib227","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neurobiolaging.2016.08.019","article-title":"Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly","volume":"49","author":"Cattaneo","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.prp.2025.156109_bib228","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.3233\/JAD-180176","article-title":"Gut Microbiota is Altered in Patients with Alzheimer\u2019s Disease","volume":"63","author":"Zhuang","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.prp.2025.156109_bib229","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.jalz.2019.07.002","article-title":"Mild cognitive impairment has similar alterations as Alzheimer\u2019s disease in gut microbiota","volume":"15","author":"Li","year":"2019","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.prp.2025.156109_bib230","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.bbi.2019.05.008","article-title":"Altered microbiomes distinguish Alzheimer\u2019s disease from amnestic mild cognitive impairment and health in a Chinese cohort","volume":"80","author":"Liu","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.prp.2025.156109_bib231","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-13601-y","article-title":"Gut microbiome alterations in Alzheimer\u2019s disease","volume":"7","author":"Vogt","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2025.156109_bib232","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.4049\/jimmunol.1200947","article-title":"IFN-\u03b3 Production by amyloid \u03b2-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer\u2019s disease","volume":"190","author":"Browne","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.prp.2025.156109_bib233","doi-asserted-by":"crossref","first-page":"927","DOI":"10.3233\/JAD-2010-091696","article-title":"PD1 negative and PD1 positive CD4+ T regulatory cells in mild cognitive impairment and Alzheimer\u2019s disease","volume":"21","author":"Saresella","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.prp.2025.156109_bib234","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jneuroim.2011.11.005","article-title":"Immune profiling of Alzheimer patients","volume":"242","author":"Pellican\u00f2","year":"2012","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.prp.2025.156109_bib235","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.mib.2012.12.001","article-title":"Microbial amyloids--functions and interactions within the host","volume":"16","author":"Schwartz","year":"2013","journal-title":"Curr. Opin. Microbiol"},{"key":"10.1016\/j.prp.2025.156109_bib236","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3233\/JAD-142841","article-title":"Mechanisms of molecular mimicry involving the microbiota in neurodegeneration","volume":"45","author":"Friedland","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.prp.2025.156109_bib237","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3233\/JAD-160926","article-title":"Altered gut microbiome composition and tryptic activity of the 5xFAD Alzheimer\u2019s mouse model","volume":"56","author":"Brandscheid","year":"2017","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.prp.2025.156109_bib238","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba0466","article-title":"Gut dysbiosis contributes to amyloid pathology, associated with C\/EBP\u03b2\/AEP signaling activation in Alzheimer\u2019s disease mouse model","volume":"6","author":"Chen","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.prp.2025.156109_bib239","doi-asserted-by":"crossref","first-page":"S195","DOI":"10.3233\/JAD-201367","article-title":"Gut microbiota alterations and cognitive impairment are sexually dissociated in a transgenic mice model of Alzheimer\u2019s disease","volume":"82","author":"Cuervo-Zanatta","year":"2021","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.prp.2025.156109_bib240","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.3390\/ijms21051711","article-title":"Dysregulated gut homeostasis observed prior to the accumulation of the brain amyloid-\u03b2 in Tg2576 mice","volume":"21","author":"Honarpisheh","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.prp.2025.156109_bib241","article-title":"Clinical insights into the mechanisms of infectious microbes and microbiota in chronic neurologic and psychiatric diseases","volume":"272","author":"Faysal","year":"2025","journal-title":"Pathol. Res Pr."},{"key":"10.1016\/j.prp.2025.156109_bib242","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.1128\/jvi.69.8.4898-4905.1995","article-title":"Gamma interferon expression during acute and latent nervous system infection by herpes simplex virus type 1","volume":"69","author":"Cantin","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.prp.2025.156109_bib243","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s13365-011-0063-0","article-title":"Control of HSV-1 latency in human trigeminal ganglia--current overview","volume":"17","author":"Held","year":"2011","journal-title":"J. Neurovirol"},{"key":"10.1016\/j.prp.2025.156109_bib244","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3233\/JAD-2008-13405","article-title":"Herpes simplex virus type 1 in Alzheimer\u2019s disease: The enemy within","volume":"13","author":"Itzhaki","year":"2008","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.prp.2025.156109_bib245","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/ana.10662","article-title":"Herpesviruses in brains in Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"54","author":"Hemling","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.prp.2025.156109_bib246","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/path.1711670403","article-title":"Herpes simplex virus type 1 DNA is present in specific regions of brain from aged people with and without senile dementia of the Alzheimer type","volume":"167","author":"Jamieson","year":"1992","journal-title":"J. Pathol."},{"key":"10.1016\/j.prp.2025.156109_bib247","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/jmv.1890330403","article-title":"Latent herpes simplex virus type 1 in normal and Alzheimer\u2019s disease brains","volume":"33","author":"Jamieson","year":"1991","journal-title":"J. Med Virol."},{"key":"10.1016\/j.prp.2025.156109_bib248","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3389\/fnagi.2014.00202","article-title":"Herpes simplex virus type 1 and Alzheimer\u2019s disease: increasing evidence for a major role of the virus","volume":"6","author":"Itzhaki","year":"2014","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.prp.2025.156109_bib249","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.tim.2020.03.003","article-title":"Herpes Simplex virus-1 in the brain: the dark side of a sneaky infection","volume":"28","author":"Marcocci","year":"2020","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.prp.2025.156109_bib250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007617","article-title":"Recurrent herpes simplex virus-1 infection induces hallmarks of neurodegeneration and cognitive deficits in mice","volume":"15","author":"De Chiara","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.prp.2025.156109_bib251","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neulet.2007.09.077","article-title":"Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation","volume":"429","author":"Wozniak","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.prp.2025.156109_bib252","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021456","article-title":"Activation of PKR causes amyloid \u00df-peptide accumulation via De-Repression of Bace1 expression","volume":"6","author":"ILL-Raga","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2025.156109_bib253","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3233\/JAD-2008-14301","article-title":"Neuronal cytoskeletal dynamic modification and neurodegeneration induced by infection with herpes simplex virus type 1","volume":"14","author":"Zambrano","year":"2008","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.prp.2025.156109_bib254","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41398-023-02376-8","article-title":"HSV-1 cellular model reveals links between aggresome formation and early step of Alzheimer\u2019s disease","volume":"13","author":"Albaret","year":"2023","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.prp.2025.156109_bib255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/microorganisms8070972","article-title":"Multiple herpes simplex virus-1 (HSV-1) reactivations induce protein oxidative damage in mouse brain: Novel mechanisms for alzheimer\u2019s disease progression","volume":"8","author":"Protto","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.prp.2025.156109_bib256","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yexcr.2004.01.002","article-title":"Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5\/p35 pathway","volume":"295","author":"Quintanilla","year":"2004","journal-title":"Exp. Cell Res"},{"key":"10.1016\/j.prp.2025.156109_bib257","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-2094-2-9","article-title":"Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer\u2019s disease","volume":"2","author":"Patel","year":"2005","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.prp.2025.156109_bib258","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nri3452","article-title":"Activation and regulation of the inflammasomes","volume":"13","author":"Latz","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.prp.2025.156109_bib259","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.neulet.2019.03.016","article-title":"Endo-lysosomal pathway and ubiquitin-proteasome system dysfunction in Alzheimer\u2019s disease pathogenesis","volume":"703","author":"Cao","year":"2019","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.prp.2025.156109_bib260","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1179\/1743132813Y.0000000288","article-title":"Relationship between amyloid-beta and the ubiquitin-proteasome system in Alzheimer\u2019s disease","volume":"36","author":"Hong","year":"2014","journal-title":"Neurol. Res"},{"key":"10.1016\/j.prp.2025.156109_bib261","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1046\/j.1471-4159.2003.01642.x","article-title":"Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer\u2019s disease","volume":"85","author":"Keck","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.prp.2025.156109_bib262","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1046\/j.1471-4159.2000.0750436.x","article-title":"Impaired proteasome function in Alzheimer\u2019s disease","volume":"75","author":"Keller","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.prp.2025.156109_bib263","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.mad.2005.07.006","article-title":"Amyloid peptide attenuates the proteasome activity in neuronal cells","volume":"126","author":"Oh","year":"2005","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.prp.2025.156109_bib264","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1523\/JNEUROSCI.5078-05.2006","article-title":"\u03b2-amyloid accumulation impairs multivesicular body sorting by inhibiting the ubiquitin-proteasome system","volume":"26","author":"Almeida","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.prp.2025.156109_bib265","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.neurobiolaging.2007.04.014","article-title":"Abeta inhibits the proteasome and enhances amyloid and tau accumulation","volume":"29","author":"Tseng","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.prp.2025.156109_bib266","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0003-9861(02)00493-9","article-title":"Proteasome-mediated degradation of tau proteins occurs independently of the chymotrypsin-like activity by a nonprocessive pathway","volume":"408","author":"Cardozo","year":"2002","journal-title":"Arch. Biochem Biophys."},{"key":"10.1016\/j.prp.2025.156109_bib267","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad1904","article-title":"The E3 ubiquitin ligase Idol controls brain LDL receptor expression, ApoE clearance, and A\u03b2 amyloidosis","volume":"7","author":"Choi","year":"2015","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.prp.2025.156109_bib268","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1582-4934.2008.00276.x","article-title":"Popescu BO. The ubiquitin-proteasome system in Alzheimer\u2019s disease","volume":"12","author":"Oddo","year":"2008","journal-title":"J. Cell Mol. Med"},{"key":"10.1016\/j.prp.2025.156109_bib269","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1582-4934.2008.00557.x","article-title":"Chaperone signalling complexes in Alzheimer\u2019s disease","volume":"13","author":"Koren","year":"2009","journal-title":"J. Cell Mol. Med"},{"key":"10.1016\/j.prp.2025.156109_bib270","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2020.581374","article-title":"Molecular chaperones: A double-edged sword in neurodegenerative diseases","volume":"12","author":"Tittelmeier","year":"2020","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.prp.2025.156109_bib271","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/978-3-319-57379-3_20","article-title":"Molecular chaperones in neurodegenerative diseases: A short review. Adv. Exp. Med. Biol","volume":"987","author":"Bobori","year":"2017","journal-title":"Adv. Exp. Med Biol."},{"key":"10.1016\/j.prp.2025.156109_bib272","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.neulet.2012.11.010","article-title":"Proteomic analysis of the hippocampus in Alzheimer\u2019s disease model mice by using two-dimensional fluorescence difference in gel electrophoresis","volume":"534","author":"Takano","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.prp.2025.156109_bib273","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/j.bmcl.2007.01.017","article-title":"A non-toxic Hsp90 inhibitor protects neurons from Abeta-induced toxicity","volume":"17","author":"Ansar","year":"2007","journal-title":"Bioorg. Med Chem. Lett."},{"key":"10.1016\/j.prp.2025.156109_bib274","doi-asserted-by":"crossref","first-page":"33182","DOI":"10.1074\/jbc.M606192200","article-title":"Heat shock proteins 70 and 90 inhibit early stages of amyloid beta-(1-42) aggregation in vitro","volume":"281","author":"Evans","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2025.156109_bib275","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1523\/JNEUROSCI.4330-03.2004","article-title":"Heat shock protein 70 participates in the neuroprotective response to intracellularly expressed beta-amyloid in neurons","volume":"24","author":"Magran\u00e9","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.prp.2025.156109_bib276","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2990.2006.00689.x","article-title":"Specific association of small heat shock proteins with the pathological hallmarks of Alzheimer\u2019s disease brains","volume":"32","author":"Wilhelmus","year":"2006","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.prp.2025.156109_bib277","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1021\/acschembio.7b01039","article-title":"Hsp70 inhibits the nucleation and elongation of tau and sequesters tau aggregates with high affinity","volume":"13","author":"Kundel","year":"2018","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.prp.2025.156109_bib278","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1073\/pnas.242720499","article-title":"Chaperones increase association of tau protein with microtubules","volume":"100","author":"Dou","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.prp.2025.156109_bib279","doi-asserted-by":"crossref","first-page":"29468","DOI":"10.1074\/jbc.M602533200","article-title":"Differential effects of mitochondrial heat shock protein 60 and related molecular chaperones to prevent intracellular beta-amyloid-induced inhibition of complex IV and limit apoptosis","volume":"281","author":"Veereshwarayya","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2025.156109_bib280","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0014-5793(89)81671-0","article-title":"Interleukin 1 and tumour necrosis factor increase phosphorylation of the small heat shock protein. Effects in fibroblasts, Hep G2 and U937 cells","volume":"258","author":"Kaur","year":"1989","journal-title":"FEBS Lett."},{"key":"10.1016\/j.prp.2025.156109_bib281","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1096\/fj.01-0530fje","article-title":"Microglial activation and amyloid-beta clearance induced by exogenous heat-shock proteins","volume":"16","author":"Kakimura","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.prp.2025.156109_bib282","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1177\/0960327118758152","article-title":"Paraquat-induced inflammatory response of microglia through HSP60\/TLR4 signaling","volume":"37","author":"Sun","year":"2018","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.prp.2025.156109_bib283","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrm2882","article-title":"The emerging mechanisms of isoform-specific PI3K signalling","volume":"11","author":"Vanhaesebroeck","year":"2010","journal-title":"Nat. Rev. Mol. Cell"},{"key":"10.1016\/j.prp.2025.156109_bib284","first-page":"1","article-title":"Interaction between amyloid beta toxicity and the PI3K pathway in Alzheimer\u2019s disease","volume":"6","author":"Choi","year":"2016","journal-title":"J. Alzheimer\u2019S. Dis. Park"},{"key":"10.1016\/j.prp.2025.156109_bib285","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2174\/1567205015666181022093359","article-title":"Astrocytic \u03b17 nicotinic receptor activation inhibits amyloid-\u03b2 aggregation by upregulating endogenous \u03b1B-crystallin through the PI3K\/Akt signaling pathway","volume":"16","author":"Ren","year":"2018","journal-title":"Curr. Alzheimer Res"},{"key":"10.1016\/j.prp.2025.156109_bib286","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neuint.2019.04.006","article-title":"Exendin-4 attenuates brain mitochondrial toxicity through PI3K\/Akt-dependent pathway in amyloid beta (1-42)-induced cognitive deficit rats","volume":"128","author":"Garabadu","year":"2019","journal-title":"Neurochem. Int"},{"key":"10.1016\/j.prp.2025.156109_bib287","doi-asserted-by":"crossref","first-page":"10960","DOI":"10.1523\/JNEUROSCI.1723-05.2005","article-title":"Intraneuronal \u03b2-amyloid expression downregulates the Akt survival pathway and blunts the stress response","volume":"25","author":"Magran\u00e9","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.prp.2025.156109_bib288","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/jnc.12334","article-title":"Endothelial nitric oxide deficiency promotes Alzheimer\u2019s disease pathology","volume":"127","author":"Austin","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.prp.2025.156109_bib289","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ejphar.2014.06.051","article-title":"Downregulation of PI3K\/Akt\/mTOR signaling pathway in curcumin-induced autophagy in APP\/PS1 double transgenic mice","volume":"740","author":"Wang","year":"2014","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.prp.2025.156109_bib290","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.exger.2013.02.025","article-title":"PI3-kinase\/Akt\/mTOR signaling: impaired on\/off switches in aging, cognitive decline and Alzheimer\u2019s disease","volume":"48","author":"O\u2019Neill","year":"2013","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.prp.2025.156109_bib291","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1074\/jbc.M112.409250","article-title":"Inhibition of glycogen synthase kinase-3 ameliorates \u03b2-amyloid pathology and restores lysosomal acidification and mammalian target of rapamycin activity in the Alzheimer disease mouse model: in vivo and in vitro studies","volume":"288","author":"Avrahami","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2025.156109_bib292","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nature01640","article-title":"GSK-3alpha regulates production of Alzheimer\u2019s disease amyloid-beta peptides","volume":"423","author":"Phiel","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.prp.2025.156109_bib293","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.brainres.2007.10.064","article-title":"Amyloid-beta-induced neurotoxicity is reduced by inhibition of glycogen synthase kinase-3","volume":"1188","author":"Koh","year":"2008","journal-title":"Brain Res"},{"key":"10.1016\/j.prp.2025.156109_bib294","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.neurobiolaging.2011.02.003","article-title":"AGEs induce Alzheimer-like tau pathology and memory deficit via RAGE-mediated GSK-3 activation","volume":"33","author":"Li","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.prp.2025.156109_bib295","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s12035-021-02611-7","article-title":"Implications of phosphoinositide 3-kinase-Akt (PI3K-Akt) pathway in the pathogenesis of Alzheimer\u2019s disease","volume":"59","author":"Kumar","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.prp.2025.156109_bib296","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.neuint.2009.09.011","article-title":"Cholinergic protection via alpha7 nicotinic acetylcholine receptors and PI3K-Akt pathway in LPS-induced neuroinflammation","volume":"56","author":"Tyagi","year":"2010","journal-title":"Neurochem. Int"},{"key":"10.1016\/j.prp.2025.156109_bib297","doi-asserted-by":"crossref","first-page":"11300","DOI":"10.1523\/JNEUROSCI.2270-05.2005","article-title":"Control of dendritic arborization by the phosphoinositide-3\u2032-kinase- Akt-mammalian target of rapamycin pathway","volume":"25","author":"Jaworski","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.prp.2025.156109_bib298","doi-asserted-by":"crossref","first-page":"11288","DOI":"10.1523\/JNEUROSCI.2284-05.2005","article-title":"Regulation of dendritic morphogenesis by Ras-PI3K-Akt-mTOR and Ras-MAPK signaling pathways","volume":"25","author":"Kumar","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.prp.2025.156109_bib299","article-title":"Propofol reduces inflammatory brain injury after subarachnoid hemorrhage: Involvement of PI3K\/Akt pathway","volume":"28","author":"Zhang","year":"2019","journal-title":"J. Stroke Cereb. Dis."},{"key":"10.1016\/j.prp.2025.156109_bib300","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s11064-016-2124-5","article-title":"Antidepressant-like effect of isorhynchophylline in mice","volume":"42","author":"Xian","year":"2017","journal-title":"Neurochem. Res"},{"key":"10.1016\/j.prp.2025.156109_bib301","doi-asserted-by":"crossref","first-page":"446","DOI":"10.4049\/jimmunol.178.1.446","article-title":"Opposite regulation of IL-1\u03b2 and secreted IL-1 receptor antagonist production by phosphatidylinositide-3 kinases in human monocytes activated by lipopolysaccharides or contact with T cells","volume":"178","author":"Molnarfi","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.prp.2025.156109_bib302","first-page":"13437","article-title":"Effects of PI3K\/Akt signaling pathway on serum C-reactive protein, serum amyloid A and cognitive dysfunction in mice with Alzheimer\u2019s disease","volume":"12","author":"Zhang","year":"2019","journal-title":"Int J. Clin. Exp. Med 2019"},{"key":"10.1016\/j.prp.2025.156109_bib303","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.neurobiolaging.2007.02.029","article-title":"Alzheimer\u2019s disease-type neuronal tau hyperphosphorylation induced by A beta oligomers","volume":"29","author":"De Felice","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.prp.2025.156109_bib304","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0092-8674(03)00929-2","article-title":"TSC2 mediates cellular energy response to control cell growth and survival","volume":"115","author":"Inoki","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.prp.2025.156109_bib305","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.devcel.2017.02.016","article-title":"Cleaning house: selective autophagy of organelles","volume":"41","author":"Anding","year":"2017","journal-title":"Dev. Cell"},{"key":"10.1016\/j.prp.2025.156109_bib306","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/sj.cdd.4400978","article-title":"Mammalian target of rapamycin (mTOR): pro- and anti-apoptotic","volume":"9","author":"Castedo","year":"2002","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.prp.2025.156109_bib307","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/bs.ircmb.2020.01.003","article-title":"Crosstalk between apoptosis and autophagy signaling pathways","volume":"352","author":"Fairlie","year":"2020","journal-title":"Int Rev. Cell Mol. Biol."},{"key":"10.1016\/j.prp.2025.156109_bib308","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2022.105311","article-title":"mTOR signaling as a molecular target for the alleviation of Alzheimer\u2019s disease pathogenesis","volume":"155","author":"Rapaka","year":"2022","journal-title":"Neurochem. Int"},{"key":"10.1016\/j.prp.2025.156109_bib309","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.2337\/db11-1735","article-title":"Altered APP processing in insulin-resistant conditions is mediated by autophagosome accumulation via the inhibition of mammalian target of rapamycin pathway","volume":"61","author":"Son","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.prp.2025.156109_bib310","doi-asserted-by":"crossref","first-page":"37415","DOI":"10.1074\/jbc.M110.186411","article-title":"Macroautophagy is not directly involved in the metabolism of amyloid precursor protein","volume":"285","author":"Boland","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2025.156109_bib311","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009979","article-title":"Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer\u2019s disease","volume":"5","author":"Spilman","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2025.156109_bib312","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.expneurol.2018.09.011","article-title":"Early intrathecal infusion of everolimus restores cognitive function and mood in a murine model of Alzheimer\u2019s disease","volume":"311","author":"Cassano","year":"2019","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.prp.2025.156109_bib313","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105013","article-title":"Neuro-nutraceutical potential of Asparagus racemosus: a review","volume":"145","author":"Majumdar","year":"2021","journal-title":"Neurochem. Int"},{"key":"10.1016\/j.prp.2025.156109_bib314","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1111\/j.1582-4934.2008.00509.x","article-title":"mTOR-dependent signalling in Alzheimer\u2019s disease","volume":"12","author":"Pei","year":"2008","journal-title":"J. Cell Mol. Med"},{"key":"10.1016\/j.prp.2025.156109_bib315","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1471-4159.2005.03187.x","article-title":"mTOR\/p70S6k signalling alteration by Abeta exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer\u2019s disease","volume":"94","author":"Lafay-Chebassier","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.prp.2025.156109_bib316","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1002\/jnr.21039","article-title":"The immunosuppressant rapamycin exacerbates neurotoxicity of Abeta peptide","volume":"84","author":"Lafay-Chebassier","year":"2006","journal-title":"J. Neurosci. Res"},{"key":"10.1016\/j.prp.2025.156109_bib317","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10571-016-0386-8","article-title":"Autophagy and Alzheimer\u2019s Disease","volume":"37","author":"Li","year":"2017","journal-title":"Cell Mol. Neurobiol."},{"key":"10.1016\/j.prp.2025.156109_bib318","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1016\/j.cellsig.2014.08.019","article-title":"The role of PI3K\/AKT\/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration","volume":"26","author":"Heras-Sandoval","year":"2014","journal-title":"Cell Signal"},{"key":"10.1016\/j.prp.2025.156109_bib319","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/jnc.13037","article-title":"Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): Analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD","volume":"133","author":"Tramutola","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.prp.2025.156109_bib320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-4-14","article-title":"The PI3K-Akt-mTOR pathway regulates a oligomer induced neuronal cell cycle events","volume":"4","author":"Bhaskar","year":"2009","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.prp.2025.156109_bib321","doi-asserted-by":"crossref","first-page":"13107","DOI":"10.1074\/jbc.M110.100420","article-title":"Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments","volume":"285","author":"Caccamo","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2025.156109_bib322","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3233\/JAD-141488","article-title":"Effect of EPHA1 genetic variation on cerebrospinal fluid and neuroimaging biomarkers in healthy, mild cognitive impairment and Alzheimer\u2019s disease cohorts","volume":"44","author":"Wang","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.prp.2025.156109_bib323","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0002-9440(10)63687-5","article-title":"Up-regulation of phosphorylated\/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer\u2019s disease","volume":"163","author":"An","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.prp.2025.156109_bib324","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/acel.12057","article-title":"mTOR regulates tau phosphorylation and degradation: implications for Alzheimer\u2019s disease and other tauopathies","volume":"12","author":"Caccamo","year":"2013","journal-title":"Aging Cell"},{"key":"10.1016\/j.prp.2025.156109_bib325","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.neuint.2013.01.014","article-title":"Rapamycin decreases tau phosphorylation at Ser214 through regulation of cAMP-dependent kinase","volume":"62","author":"Liu","year":"2013","journal-title":"Neurochem. Int"},{"key":"10.1016\/j.prp.2025.156109_bib326","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062459","article-title":"Rapamycin attenuates the progression of tau pathology in P301S tau transgenic mice","volume":"8","author":"Ozcelik","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2025.156109_bib327","doi-asserted-by":"crossref","first-page":"21978","DOI":"10.1074\/jbc.M110.110940","article-title":"A caspase cleaved form of tau is preferentially degraded through the autophagy pathway","volume":"285","author":"Dolan","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2025.156109_bib328","doi-asserted-by":"crossref","first-page":"15556","DOI":"10.1074\/jbc.M112.435123","article-title":"Mammalian target of rapamycin (mTor) mediates tau protein dyshomeostasis: Implication for Alzheimer disease","volume":"288","author":"Tang","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2025.156109_bib329","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1111\/j.1742-4658.2005.04833.x","article-title":"Levels of mTOR and its downstream targets 4E-BP1, eEF2, and eEF2 kinase in relationships with tau in Alzheimer\u2019s disease brain","volume":"272","author":"Li","year":"2005","journal-title":"FEBS J."},{"key":"10.1016\/j.prp.2025.156109_bib330","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.nlm.2007.12.004","article-title":"Systemic inhibition of mammalian target of rapamycin inhibits fear memory reconsolidation","volume":"90","author":"Blundell","year":"2008","journal-title":"Neurobiol. Learn Mem."},{"key":"10.1016\/j.prp.2025.156109_bib331","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/jnr.22725","article-title":"Sirt1 overexpression in neurons promotes neurite outgrowth and cell survival through inhibition of the mTOR signaling","volume":"89","author":"Guo","year":"2011","journal-title":"J. Neurosci. Res"},{"key":"10.1016\/j.prp.2025.156109_bib332","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.1007\/s12035-015-9425-6","article-title":"Activation of mTOR signaling mediates the increased expression of AChE in high glucose condition: in vitro and in vivo evidences","volume":"53","author":"Liu","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.prp.2025.156109_bib333","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jalz.2016.08.015","article-title":"mTOR and neuronal cell cycle reentry: How impaired brain insulin signaling promotes Alzheimer\u2019s disease","volume":"13","author":"Norambuena","year":"2017","journal-title":"Alzheimer\u2019S. Dement"},{"key":"10.1016\/j.prp.2025.156109_bib334","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1096\/fj.10-167361","article-title":"Novel synthetic small-molecule activators of AMPK as enhancers of autophagy and amyloid-\u03b2 peptide degradation","volume":"25","author":"Vingtdeux","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.prp.2025.156109_bib335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12017-012-8173-2","article-title":"Roles of AMP-activated protein kinase in Alzheimer\u2019s disease","volume":"14","author":"Cai","year":"2012","journal-title":"Neuromolecular Med"},{"key":"10.1016\/j.prp.2025.156109_bib336","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1002\/jnr.22057","article-title":"Amyloid-beta interrupts the PI3K-Akt-mTOR signaling pathway that could be involved in brain-derived neurotrophic factor-induced Arc expression in rat cortical neurons","volume":"87","author":"Chen","year":"2009","journal-title":"J. Neurosci. Res"},{"key":"10.1016\/j.prp.2025.156109_bib337","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1111\/j.1582-4934.2008.00509.x","article-title":"mTOR-dependent signalling in Alzheimer\u2019s disease","volume":"12","author":"Pei","year":"2008","journal-title":"J. Cell Mol. Med"},{"key":"10.1016\/j.prp.2025.156109_bib338","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/978-981-13-3540-2_9","article-title":"Tortuous paths of insulin signaling and mitochondria in Alzheimer\u2019s disease. Adv. Exp. Med. Biol","volume":"1128","author":"Carvalho","year":"2019","journal-title":"Adv. Exp. Med Biol."},{"key":"10.1016\/j.prp.2025.156109_bib339","doi-asserted-by":"crossref","first-page":"9987","DOI":"10.3390\/ijms22189987","article-title":"Insulin and insulin resistance in alzheimer\u2019s disease","volume":"22","author":"S\u0229dzikowska","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.prp.2025.156109_bib340","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2174\/156720512799015037","article-title":"Brain insulin resistance and deficiency as therapeutic targets in Alzheimers disease","volume":"9","author":"M. de la Monte","year":"2012","journal-title":"Curr. Alzheimer Res"},{"key":"10.1016\/j.prp.2025.156109_bib341","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11357-006-9009-5","article-title":"Hippocampal IGF-1 expression, neurogenesis and slowed aging: Clues to longevity from mutant mice","volume":"28","author":"Sun","year":"2006","journal-title":"Age (Omaha)"},{"key":"10.1016\/j.prp.2025.156109_bib342","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41583-022-00558-9","article-title":"Impaired insulin signalling and allostatic load in Alzheimer disease","volume":"23","author":"De Felice","year":"2022","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.prp.2025.156109_bib343","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3389\/fnins.2015.00204","article-title":"Aberrant insulin signaling in Alzheimer\u2019s disease: current knowledge","volume":"9","author":"Bedse","year":"2015","journal-title":"Front Neurosci."},{"key":"10.1016\/j.prp.2025.156109_bib344","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.psyneuen.2017.05.004","article-title":"Insulin signaling: An opportunistic target to minify the risk of Alzheimer\u2019s disease","volume":"83","author":"Pardeshi","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.prp.2025.156109_bib345","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/384017","article-title":"Insulin in central nervous system: More than just a peripheral hormone","volume":"2012","author":"Duarte","year":"2012","journal-title":"J. Aging Res"},{"key":"10.1016\/j.prp.2025.156109_bib346","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.neurobiolaging.2008.04.002","article-title":"Defects in IGF-1 receptor, insulin receptor and IRS-1\/2 in Alzheimer\u2019s disease indicate possible resistance to IGF-1 and insulin signalling","volume":"31","author":"Moloney","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.prp.2025.156109_bib347","doi-asserted-by":"crossref","first-page":"RC221","DOI":"10.1523\/JNEUROSCI.22-10-j0001.2002","article-title":"Alzheimer\u2019s beta-amyloid peptides compete for insulin binding to the insulin receptor","volume":"22","author":"Xie","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.prp.2025.156109_bib348","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/nm1202-793","article-title":"Serum insulin-like growth factor I regulates brain amyloid-\u03b2 levels","volume":"8","author":"Carro","year":"2002","journal-title":"Nat. Med"},{"key":"10.1016\/j.prp.2025.156109_bib349","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.molmet.2018.01.013","article-title":"Insulin-like growth factor receptor signaling regulates working memory, mitochondrial metabolism, and amyloid-\u03b2 uptake in astrocytes","volume":"9","author":"Logan","year":"2018","journal-title":"Mol. Metab."},{"key":"10.1016\/j.prp.2025.156109_bib350","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1523\/JNEUROSCI.21-08-02561.2001","article-title":"Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling","volume":"21","author":"Gasparini","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.prp.2025.156109_bib351","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/156720509788486527","article-title":"The role of IGF-1 receptor and insulin receptor signaling for the pathogenesis of Alzheimers disease: From model organisms to human disease","volume":"6","author":"Freude","year":"2009","journal-title":"Curr. Alzheimer Res"},{"key":"10.1016\/j.prp.2025.156109_bib352","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1093\/brain\/awx256","article-title":"Tau hyperphosphorylation induces oligomeric insulin accumulation and insulin resistance in neurons","volume":"140","author":"Rodriguez-Rodriguez","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.prp.2025.156109_bib353","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/iub.1098","article-title":"The impairment of insulin signaling in Alzheimer\u2019s disease","volume":"64","author":"Candeias","year":"2012","journal-title":"IUBMB Life"},{"key":"10.1016\/j.prp.2025.156109_bib354","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1084\/jem.20161731","article-title":"Tau deletion promotes brain insulin resistance","volume":"214","author":"Marciniak","year":"2017","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.prp.2025.156109_bib355","doi-asserted-by":"crossref","first-page":"14417","DOI":"10.3390\/ijms232214417","article-title":"The role of insulin signaling in hippocampal-related diseases: A focus on Alzheimer\u2019s disease","volume":"23","author":"Liu","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.prp.2025.156109_bib356","doi-asserted-by":"crossref","first-page":"7084","DOI":"10.1523\/JNEUROSCI.23-18-07084.2003","article-title":"Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation","volume":"23","author":"Schubert","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.prp.2025.156109_bib357","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1242\/jcs.00384","article-title":"GSK-3: Tricks of the trade for a multi-tasking kinase","volume":"116","author":"Doble","year":"2003","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.prp.2025.156109_bib358","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1146\/annurev-immunol-031210-101322","article-title":"Inflammatory mechanisms in obesity","volume":"29","author":"Gregor","year":"2011","journal-title":"Annu Rev. Immunol."},{"key":"10.1016\/j.prp.2025.156109_bib359","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.cmet.2010.11.006","article-title":"Diabetes and insulin in regulation of brain cholesterol metabolism","volume":"12","author":"Suzuki","year":"2010","journal-title":"Cell Metab."},{"key":"10.1016\/j.prp.2025.156109_bib360","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3233\/JAD-2008-15412","article-title":"Potential mechanisms linking cholesterol to Alzheimer\u2019s disease-like pathology in rabbit brain, hippocampal organotypic slices, and skeletal muscle","volume":"15","author":"Ghribi","year":"2008","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.prp.2025.156109_bib361","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1212\/WNL.54.1.240","article-title":"Serum cholesterol, APOE genotype, and the risk of Alzheimer\u2019s disease: a population-based study of African Americans","volume":"54","author":"Evans","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.prp.2025.156109_bib362","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1212\/01.wnl.0000194507.39504.17","article-title":"Cholesterol, APOE genotype, and Alzheimer disease: an epidemiologic study of Nigerian Yoruba","volume":"66","author":"Hall","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.prp.2025.156109_bib363","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3233\/ADR-200238","article-title":"Dysregulation of insulin-linked metabolic pathways in Alzheimer\u2019s disease: Co-factor role of apolipoprotein E \u025b 4","volume":"4","author":"Robbins","year":"2020","journal-title":"J. Alzheimer\u2019S. Dis. Rep."},{"key":"10.1016\/j.prp.2025.156109_bib364","first-page":"1","article-title":"Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities","volume":"7","author":"Liu","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.prp.2025.156109_bib365","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2019.00227","article-title":"Wnt signaling deregulation in the aging and Alzheimer\u2019s brain","volume":"13","author":"Palomer","year":"2019","journal-title":"Front Cell Neurosci."},{"key":"10.1016\/j.prp.2025.156109_bib366","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.cellsig.2009.11.021","article-title":"Dishevelled: The hub of Wnt signaling","volume":"22","author":"Gao","year":"2010","journal-title":"Cell Signal"},{"key":"10.1016\/j.prp.2025.156109_bib367","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fnsyn.2018.00038","article-title":"Deficient Wnt signaling and synaptic vulnerability in Alzheimer\u2019s disease: Emerging roles for the LRP6 receptor","volume":"10","author":"Buechler","year":"2018","journal-title":"Front Synaptic Neurosci."},{"key":"10.1016\/j.prp.2025.156109_bib368","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13041-019-0525-5","article-title":"Restoring Wnt\/\u03b2-catenin signaling is a promising therapeutic strategy for Alzheimer\u2019s disease","volume":"12","author":"Jia","year":"2019","journal-title":"Mol. Brain"},{"key":"10.1016\/j.prp.2025.156109_bib369","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/mp.2012.163","article-title":"Clusterin regulates \u03b2-amyloid toxicity via Dickkopf-1-driven induction of the wnt-PCP-JNK pathway","volume":"19","author":"Killick","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.prp.2025.156109_bib370","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1523\/JNEUROSCI.1381-04.2004","article-title":"Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer\u2019s brain","volume":"24","author":"Caricasole","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.prp.2025.156109_bib371","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1111\/j.1471-4159.2009.06566.x","article-title":"Increased Dickkopf-1 expression in transgenic mouse models of neurodegenerative disease","volume":"112","author":"Rosi","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.prp.2025.156109_bib372","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41398-018-0231-6","article-title":"A role for APP in Wnt signalling links synapse loss with \u03b2-amyloid production","volume":"8","author":"Elliott","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.prp.2025.156109_bib373","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1523\/JNEUROSCI.4562-11.2012","article-title":"The secreted Wnt antagonist Dickkopf-1 is required for amyloid \u03b2-mediated synaptic loss","volume":"32","author":"Purro","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.prp.2025.156109_bib374","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1096\/fj.11-184697","article-title":"Reduction in paracrine Wnt3 factors during aging causes impaired adult neurogenesis","volume":"25","author":"Okamoto","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.prp.2025.156109_bib375","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuron.2014.08.048","article-title":"Deficiency in LRP6-mediated Wnt signaling contributes to synaptic abnormalities and amyloid pathology in Alzheimer\u2019s disease","volume":"84","author":"Liu","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.prp.2025.156109_bib376","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1172\/JCI73015","article-title":"Phosphatase WIP1 regulates adult neurogenesis and WNT signaling during aging","volume":"124","author":"Zhu","year":"2014","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.prp.2025.156109_bib377","doi-asserted-by":"crossref","DOI":"10.1186\/1478-811X-12-23","article-title":"Signaling pathway cross talk in Alzheimer\u2019s disease","volume":"12","author":"Godoy","year":"2014","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.prp.2025.156109_bib378","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s12035-018-1103-z","article-title":"Impaired Wnt signaling in the prefrontal cortex of Alzheimer\u2019s disease","volume":"56","author":"Folke","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.prp.2025.156109_bib379","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13024-017-0159-y","article-title":"Dynamic presenilin 1 and synaptotagmin 1 interaction modulates exocytosis and amyloid \u03b2 production","volume":"12","author":"Zoltowska","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.prp.2025.156109_bib380","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1097\/00001756-199908200-00017","article-title":"The role of beta-catenin stability in mutant PS1-associated apoptosis","volume":"10","author":"Weihl","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.prp.2025.156109_bib381","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/5526","article-title":"Presenilin mutations associated with Alzheimer disease cause defective intracellular trafficking of beta-catenin, a component of the presenilin protein complex","volume":"5","author":"Nishimura","year":"1999","journal-title":"Nat. Med"},{"key":"10.1016\/j.prp.2025.156109_bib382","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1093\/genetics\/155.4.1725","article-title":"A screen for mutations that suppress the phenotype of Drosophila armadillo, the beta-catenin homolog","volume":"155","author":"Cox","year":"2000","journal-title":"Genetics"},{"key":"10.1016\/j.prp.2025.156109_bib383","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/27208","article-title":"Destabilization of beta-catenin by mutations in presenilin-1 potentiates neuronal apoptosis","volume":"395","author":"Zhang","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.prp.2025.156109_bib384","doi-asserted-by":"crossref","first-page":"5360","DOI":"10.1523\/JNEUROSCI.19-13-05360.1999","article-title":"Mutant presenilin-1 induces apoptosis and downregulates Akt\/PKB","volume":"19","author":"Weihl","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.prp.2025.156109_bib385","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1523\/JNEUROSCI.2459-16.2017","article-title":"TREM2 promotes microglial survival by activating Wnt\/\u03b2-Catenin pathway","volume":"37","author":"Zheng","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.prp.2025.156109_bib386","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuron.2014.08.048","article-title":"Deficiency in LRP6-mediated Wnt signaling contributes to synaptic abnormalities and amyloid pathology in Alzheimer\u2019s disease","volume":"84","author":"Liu","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.prp.2025.156109_bib387","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00401-018-1815-1","article-title":"Functional morphology of the blood-brain barrier in health and disease","volume":"135","author":"Liebner","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.prp.2025.156109_bib388","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.devcel.2014.08.018","article-title":"Gpr124 controls CNS angiogenesis and blood-brain barrier integrity by promoting ligand-specific canonical wnt signaling","volume":"31","author":"Zhou","year":"2014","journal-title":"Dev. Cell"},{"key":"10.1016\/j.prp.2025.156109_bib389","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nm.4309","article-title":"Gpr124 is essential for blood-brain barrier integrity in central nervous system disease","volume":"23","author":"Chang","year":"2017","journal-title":"Nat. Med"},{"key":"10.1016\/j.prp.2025.156109_bib390","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.celrep.2018.09.045","article-title":"A RECK-WNT7 receptor-ligand interaction enables isoform-specific regulation of Wnt bioavailability","volume":"25","author":"Vallon","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.prp.2025.156109_bib391","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1083\/jcb.200806024","article-title":"Wnt\/beta-catenin signaling controls development of the blood-brain barrier","volume":"183","author":"Liebner","year":"2008","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.prp.2025.156109_bib392","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1073\/pnas.0805165106","article-title":"Wnt\/beta-catenin signaling is required for CNS, but not non-CNS, angiogenesis","volume":"106","author":"Daneman","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.prp.2025.156109_bib393","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1111\/j.1471-4159.2008.05537.x","article-title":"Activation of \u03b2-catenin signalling by GSK-3 inhibition increases p-glycoprotein expression in brain endothelial cells","volume":"106","author":"Lim","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.prp.2025.156109_bib394","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/jnc.12380","article-title":"Dysregulation of leptin signaling in Alzheimer disease: evidence for neuronal leptin resistance","volume":"128","author":"Bonda","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.prp.2025.156109_bib395","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1373\/clinchem.2010.144006","article-title":"Leptin: the missing link in Alzheimer disease?","volume":"56","author":"Harvey","year":"2010","journal-title":"Clin. Chem."},{"key":"10.1016\/j.prp.2025.156109_bib396","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cca.2015.08.009","article-title":"Leptin in Alzheimer\u2019s disease","volume":"450","author":"Magalh\u00e3es","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.prp.2025.156109_bib397","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/gerona\/glab267","article-title":"Adiponectin, leptin, and resistin and the risk of dementia","volume":"77","author":"Mooldijk","year":"2022","journal-title":"J. Gerontol. Ser. A Biol. Sci. Med Sci."},{"key":"10.1016\/j.prp.2025.156109_bib398","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1001\/jama.2009.1836","article-title":"Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging","volume":"302","author":"Lieb","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.prp.2025.156109_bib399","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.biopsych.2008.10.006","article-title":"Relationship between plasma leptin level and brain structure in elderly: a voxel-based morphometric study","volume":"65","author":"Narita","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.prp.2025.156109_bib400","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1096\/fj.04-2572com","article-title":"Obesity-related leptin regulates Alzheimer\u2019s Ab","volume":"18","author":"Fewlass","year":"2004","journal-title":"eta. FASEB J."},{"key":"10.1016\/j.prp.2025.156109_bib401","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2217\/thy.11.57","article-title":"Repositioning leptin as a therapy for Alzheimer\u2019s disease","volume":"8","author":"Johnston","year":"2011","journal-title":"Therapy"},{"key":"10.1016\/j.prp.2025.156109_bib402","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.bbrc.2008.09.026","article-title":"Leptin reduces Alzheimer\u2019s disease-related tau phosphorylation in neuronal cells","volume":"376","author":"Greco","year":"2008","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.prp.2025.156109_bib403","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.bbrc.2009.01.041","article-title":"Leptin regulates tau phosphorylation and amyloid through AMPK in neuronal cells","volume":"380","author":"Greco","year":"2009","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.prp.2025.156109_bib404","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000442616","article-title":"Leptin regulates tau phosphorylation through wnt signaling pathway in PC12 cells","volume":"24","author":"Zhang","year":"2016","journal-title":"NeuroSignals"},{"key":"10.1016\/j.prp.2025.156109_bib405","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.neulet.2009.03.066","article-title":"Leptin inhibits glycogen synthase kinase-3\u03b2 to prevent tau phosphorylation in neuronal cells","volume":"455","author":"Greco","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.prp.2025.156109_bib406","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1042\/BST0331029","article-title":"Leptin: a potential cognitive enhancer?","volume":"33","author":"Harvey","year":"2005","journal-title":"Biochem Soc. Trans."},{"key":"10.1016\/j.prp.2025.156109_bib407","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.21-24-j0001.2001","article-title":"Leptin enhances NMDA receptor function and modulates hippocampal synaptic plasticity","volume":"21","author":"Shanley","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.prp.2025.156109_bib408","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0306-4522(02)00162-8","article-title":"Impairment of long-term potentiation and spatial memory in leptin receptor-deficient rodents","volume":"113","author":"Li","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.prp.2025.156109_bib409","doi-asserted-by":"crossref","first-page":"18238","DOI":"10.1074\/jbc.M800053200","article-title":"Leptin increases adult hippocampal neurogenesis in vivo and in vitro","volume":"283","author":"Garza","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2025.156109_bib410","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/gt.2013.85","article-title":"Leptin gene therapy attenuates neuronal damages evoked by amyloid-\u03b2 and rescues memory deficits in APP\/PS1 mice","volume":"21","author":"P\u00e9rez-Gonz\u00e1lez","year":"2014","journal-title":"Gene Ther."},{"key":"10.1016\/j.prp.2025.156109_bib411","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.peptides.2005.10.006","article-title":"Effects of leptin on memory processing","volume":"27","author":"Farr","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.prp.2025.156109_bib412","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1042\/BJ20051578","article-title":"Intracellular signalling pathways activated by leptin","volume":"393","author":"Fr\u00fchbeck","year":"2006","journal-title":"Biochem J."},{"key":"10.1016\/j.prp.2025.156109_bib413","doi-asserted-by":"crossref","first-page":"4747","DOI":"10.1074\/jbc.M007439200","article-title":"Divergent roles of SHP-2 in ERK activation by leptin receptors","volume":"276","author":"Bj\u00f8rb\u00e6k","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2025.156109_bib414","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cellbi.2003.12.003","article-title":"Leptin-induced signal transduction pathways","volume":"28","author":"Hegyi","year":"2004","journal-title":"Cell Biol. Int"},{"key":"10.1016\/j.prp.2025.156109_bib415","doi-asserted-by":"crossref","first-page":"32686","DOI":"10.1074\/jbc.272.51.32686","article-title":"Divergent signaling capacities of the long and short isoforms of the leptin receptor","volume":"272","author":"Bj\u00f8rb\u00e6k","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2025.156109_bib416","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.3233\/JAD-2010-1308","article-title":"Leptin reduces pathology and improves memory in a transgenic mouse model of Alzheimer\u2019s disease","volume":"19","author":"Greco","year":"2010","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.prp.2025.156109_bib417","article-title":"Chronic leptin supplementation ameliorates pathology and improves cognitive performance in a transgenic mouse model of alzheimer\u2019s disease","author":"Greco","year":"2009","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.prp.2025.156109_bib418","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1006\/bbrc.1998.8680","article-title":"Leptin regulation of peroxisome proliferator-activated receptor-gamma, tumor necrosis factor, and uncoupling protein-2 expression in adipose tissues","volume":"246","author":"Qian","year":"1998","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.prp.2025.156109_bib419","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3233\/JAD-2009-1021","article-title":"Leptin: a novel therapeutic strategy for Alzheimer\u2019s disease","volume":"16","author":"Tezapsidis","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.prp.2025.156109_bib420","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/acel.12281","article-title":"Alterations in brain leptin signalling in spite of unchanged CSF leptin levels in Alzheimer\u2019s disease","volume":"14","author":"Maioli","year":"2015","journal-title":"Aging Cell"},{"key":"10.1016\/j.prp.2025.156109_bib421","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7861\/clinmedicine.16-3-247","article-title":"Drug treatments in Alzheimer\u2019s disease","volume":"16","author":"Briggs","year":"2016","journal-title":"Clin. Med"},{"key":"10.1016\/j.prp.2025.156109_bib422","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3390\/pharmaceutics14061117","article-title":"Therapeutic approach to Alzheimer\u2019s disease: Current treatments and new perspectives","volume":"14","author":"Pardo-Moreno","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.prp.2025.156109_bib423","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3233\/JAD-121990","article-title":"Slow excitotoxicity in Alzheimer\u2019s disease","volume":"35","author":"Ong","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.prp.2025.156109_bib424","article-title":"Alzheimer\u2019s disease drug development pipeline: 2025","volume":"11","author":"Cummings","year":"2025","journal-title":"Alzheimer\u2019S. Dement Transl. Res Clin. Inter."},{"key":"10.1016\/j.prp.2025.156109_bib425","article-title":"Therapeutic approaches to microglial dysfunction in Alzheimer\u2019s disease: Enhancing phagocytosis and metabolic regulation","volume":"263","author":"Almalki","year":"2024","journal-title":"Pathol. Res Pr."},{"key":"10.1016\/j.prp.2025.156109_bib426","article-title":"Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Alzheimer\u2019s disease","volume":"253","author":"Abdelmaksoud","year":"2024","journal-title":"Pathol. Res Pr."},{"key":"10.1016\/j.prp.2025.156109_bib427","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113320","article-title":"Alzheimer\u2019s disease and its treatment by different approaches: A review","volume":"216","author":"Srivastava","year":"2021","journal-title":"Eur. J. Med Chem."},{"key":"10.1016\/j.prp.2025.156109_bib428","doi-asserted-by":"crossref","first-page":"6539","DOI":"10.4049\/jimmunol.1100620","article-title":"Blocking IL-1 signaling rescues cognition, attenuates tau pathology, and restores neuronal \u03b2-catenin pathway function in an Alzheimer\u2019s disease model","volume":"187","author":"Kitazawa","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.prp.2025.156109_bib429","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.brainres.2010.10.053","article-title":"Anti-TNF-\u03b1 reduces amyloid plaques and tau phosphorylation and induces CD11c-positive dendritic-like cell in the APP\/PS1 transgenic mouse brains","volume":"1368","author":"Shi","year":"2011","journal-title":"Brain Res"},{"key":"10.1016\/j.prp.2025.156109_bib430","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/35050110","article-title":"A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer\u2019s disease","volume":"408","author":"Janus","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.prp.2025.156109_bib431","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nn842","article-title":"Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer\u2019s disease model","volume":"5","author":"Dodart","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.prp.2025.156109_bib432","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1080\/15548627.2018.1438807","article-title":"Cholesterol impairs autophagy-mediated clearance of amyloid beta while promoting its secretion","volume":"14","author":"Barbero-Camps","year":"2018","journal-title":"Autophagy"},{"key":"10.1016\/j.prp.2025.156109_bib433","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s11011-016-9803-4","article-title":"Atorvastatin ameliorates cognitive impairment, A\u03b21-42 production and Tau hyperphosphorylation in APP\/PS1 transgenic mice","volume":"31","author":"Zhou","year":"2016","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.prp.2025.156109_bib434","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/cns.13086","article-title":"Baicalin mitigates cognitive impairment and protects neurons from microglia-mediated neuroinflammation via suppressing NLRP3 inflammasomes and TLR4\/NF-\u03baB signaling pathway","volume":"25","author":"Jin","year":"2019","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.prp.2025.156109_bib435","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4751349","article-title":"Baicalin ameliorates cognitive impairment and protects microglia from LPS-induced neuroinflammation via the SIRT1\/HMGB1 pathway","volume":"2020","author":"Li","year":"2020","journal-title":"Oxid. Med Cell Longev."},{"key":"10.1016\/j.prp.2025.156109_bib436","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.3233\/JAD-180497","article-title":"Berberine alleviates tau hyperphosphorylation and axonopathy-associated with diabetic encephalopathy via restoring PI3K\/Akt\/GSK3\u03b2 pathway","volume":"65","author":"Wang","year":"2018","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.prp.2025.156109_bib437","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.2147\/DDDT.S235969","article-title":"Chlorogenic acid alleviates A\u03b225-35-induced autophagy and cognitive impairment via the mTOR\/TFEB signaling pathway","volume":"14","author":"Gao","year":"2020","journal-title":"Drug Des. Devel Ther."},{"key":"10.1016\/j.prp.2025.156109_bib438","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106263","article-title":"CSB6B prevents \u03b2-amyloid-associated neuroinflammation and cognitive impairments via inhibiting NF-\u03baB and NLRP3 in microglia cells","volume":"81","author":"Yan","year":"2020","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.prp.2025.156109_bib439","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cbi.2019.01.010","article-title":"Curcumin analogues attenuate A\u03b225-35-induced oxidative stress in PC12 cells via Keap1\/Nrf2\/HO-1 signaling pathways","volume":"305","author":"Xu","year":"2019","journal-title":"Chem. Biol. Inter."},{"key":"10.1016\/j.prp.2025.156109_bib440","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bbrc.2019.01.103","article-title":"Dulaglutide ameliorates STZ induced AD-like impairment of learning and memory ability by modulating hyperphosphorylation of tau and NFs through GSK3\u03b2","volume":"511","author":"Zhou","year":"2019","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.prp.2025.156109_bib441","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/s11064-022-03853-0","article-title":"Dulaglutide improves gliosis and suppresses aoptosis\/autophagy through the PI3K\/Akt\/mTOR signaling pathway in vascular dementia rats","volume":"48","author":"Guan","year":"2023","journal-title":"Neurochem. Res"},{"key":"10.1016\/j.prp.2025.156109_bib442","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.phrs.2016.02.007","article-title":"The antineoplastic drug flavopiridol reverses memory impairment induced by Amyloid-\u00df1-42 oligomers in mice","volume":"106","author":"Leggio","year":"2016","journal-title":"Pharm. Res"},{"key":"10.1016\/j.prp.2025.156109_bib443","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.neuropharm.2017.08.037","article-title":"Fluoxetine administration during adolescence attenuates cognitive and synaptic deficits in adult 3\u00d7TgAD mice","volume":"126","author":"Sun","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.prp.2025.156109_bib444","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.00693","article-title":"Fluoxetine and vortioxetine reverse depressive-like phenotype and memory deficits induced by A\u03b21-42 oligomers in mice: A key role of transforming growth factor-\u03b21","volume":"10","author":"Torrisi","year":"2019","journal-title":"Front Pharm."},{"key":"10.1016\/j.prp.2025.156109_bib445","doi-asserted-by":"crossref","first-page":"8166","DOI":"10.1007\/s12035-024-04484-y","article-title":"Polypharmacology and neuroprotective effects of gingerol in Alzheimer\u2019s disease","volume":"62","author":"Priyadarshini","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.prp.2025.156109_bib446","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s12906-021-03426-8","article-title":"Lactobacillus plantarum PS128 prevents cognitive dysfunction in Alzheimer\u2019s disease mice by modulating propionic acid levels, glycogen synthase kinase 3 beta activity, and gliosis","volume":"21","author":"Huang","year":"2021","journal-title":"BMC Complement Med Ther."},{"key":"10.1016\/j.prp.2025.156109_bib447","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1080\/1028415X.2021.1991556","article-title":"Lactobacillus plantarum DP189 prevents cognitive dysfunction in D-galactose\/AlCl3 induced mouse model of Alzheimer\u2019s disease via modulating gut microbiota and PI3K\/Akt\/GSK-3\u03b2 signaling pathway","volume":"25","author":"Song","year":"2022","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.prp.2025.156109_bib448","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/cns.12404","article-title":"DPP-4 inhibitor linagliptin attenuates A\u03b2-induced cytotoxicity through activation of AMPK in neuronal cells","volume":"21","author":"Kornelius","year":"2015","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.prp.2025.156109_bib449","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108662","article-title":"Linagliptin, a DPP-4 inhibitor, ameliorates A\u03b2 (1-42) peptides induced neurodegeneration and brain insulin resistance (BIR) via insulin receptor substrate-1 (IRS-1) in rat model of Alzheimer\u2019s disease","volume":"195","author":"Siddiqui","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.prp.2025.156109_bib450","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1007\/s11064-017-2250-8","article-title":"Liraglutide improves water maze learning and memory performance while reduces hyperphosphorylation of tau and neurofilaments in APP\/PS1\/Tau Triple transgenic mice","volume":"42","author":"Chen","year":"2017","journal-title":"Neurochem. Res"},{"key":"10.1016\/j.prp.2025.156109_bib451","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejphar.2016.04.052","article-title":"Subcutaneous administration of liraglutide ameliorates learning and memory impairment by modulating tau hyperphosphorylation via the glycogen synthase kinase-3\u03b2 pathway in an amyloid \u03b2 protein induced alzheimer disease mouse model","volume":"783","author":"Qi","year":"2016","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.prp.2025.156109_bib452","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.bbrc.2017.11.114","article-title":"Lixisenatide reduces amyloid plaques, neurofibrillary tangles and neuroinflammation in an APP\/PS1\/tau mouse model of Alzheimer\u2019s disease","volume":"495","author":"Cai","year":"2018","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.prp.2025.156109_bib453","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/biof.1411","article-title":"Melatonin protects against A\u03b2-induced neurotoxicity in primary neurons via miR-132\/PTEN\/AKT\/FOXO3a pathway","volume":"44","author":"Zhao","year":"2018","journal-title":"Biofactors"},{"key":"10.1016\/j.prp.2025.156109_bib454","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13195-020-00761-9","article-title":"Metformin attenuates plaque-associated tau pathology and reduces amyloid-\u03b2 burden in APP\/PS1 mice","volume":"13","author":"Chen","year":"2021","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.prp.2025.156109_bib455","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1007\/s00221-021-06176-8","article-title":"Metformin prevents p-tau and amyloid plaque deposition and memory impairment in diabetic mice","volume":"239","author":"Oliveira","year":"2021","journal-title":"Exp. Brain Res"},{"key":"10.1016\/j.prp.2025.156109_bib456","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-020-00617-2","article-title":"A selective p38\u03b1\/\u03b2 MAPK inhibitor alleviates neuropathology and cognitive impairment, and modulates microglia function in 5XFAD mouse","volume":"12","author":"Gee","year":"2020","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.prp.2025.156109_bib457","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jns.2016.07.010","article-title":"Inhibition of beta-amyloid-induced neurotoxicity by pinocembrin through Nrf2\/HO-1 pathway in SH-SY5Y cells","volume":"368","author":"Wang","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.prp.2025.156109_bib458","doi-asserted-by":"crossref","first-page":"7053","DOI":"10.1002\/jcb.27023","article-title":"Pterostilbene inhibits amyloid-\u03b2-induced neuroinflammation in a microglia cell line by inactivating the NLRP3\/caspase-1 inflammasome pathway","volume":"119","author":"Li","year":"2018","journal-title":"J. Cell Biochem"},{"key":"10.1016\/j.prp.2025.156109_bib459","first-page":"747","article-title":"Investigating the potential therapeutic mechanisms of puerarin in neurological diseases","author":"Chauhan","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.prp.2025.156109_bib460","first-page":"174","article-title":"Neuroprotective effect of quercetin through targeting key genes involved in aluminum chloride induced Alzheimer\u2019s disease in rats","volume":"10","author":"Elreedy","year":"2023","journal-title":"Egypt J. Basic Appl. Sci."},{"key":"10.1016\/j.prp.2025.156109_bib461","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jff.2016.01.036","article-title":"Quercetin attenuates tau hyperphosphorylation and improves cognitive disorder via suppression of ER stress in a manner dependent on AMPK pathway","volume":"22","author":"Chen","year":"2016","journal-title":"J. Funct. Foods"},{"key":"10.1016\/j.prp.2025.156109_bib462","article-title":"Quercetin protects against Okadaic acid-induced injury via MAPK and PI3K\/Akt\/GSK3\u03b2 signaling pathways in HT22 hippocampal neurons","volume":"11","author":"Jiang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2025.156109_bib463","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s11064-017-2421-7","article-title":"Resveratrol attenuates the cytotoxicity induced by amyloid-\u03b21\u201342 in PC12 cells by upregulating heme oxygenase-1 via the PI3K\/Akt\/Nrf2 pathway","volume":"43","author":"Hui","year":"2018","journal-title":"Neurochem. Res"},{"key":"10.1016\/j.prp.2025.156109_bib464","doi-asserted-by":"crossref","first-page":"7975","DOI":"10.1007\/s12035-024-04654-y","article-title":"Unlocking the neuroprotective potential of silymarin: A promising ally in safeguarding the brain from Alzheimer\u2019s disease and other neurological disorders","volume":"62","author":"Almutary","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.prp.2025.156109_bib465","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.3390\/molecules27165327","article-title":"Mechanistic insights into the pharmacological significance of silymarin","volume":"2022","author":"Wadhwa","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.prp.2025.156109_bib466","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4754195","article-title":"Sulforaphene ameliorates neuroinflammation and hyperphosphorylated tau protein via regulating the PI3K\/Akt\/GSK-3 \u03b2 pathway in experimental models of Alzheimer\u2019s disease","volume":"2020","author":"Yang","year":"2020","journal-title":"Oxid. Med Cell Longev."},{"key":"10.1016\/j.prp.2025.156109_bib467","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1159\/000484449","article-title":"TRPML1 participates in the progression of Alzheimer\u2019s disease by regulating the PPAR\u03b3\/AMPK\/Mtor signalling pathway","volume":"43","author":"Zhang","year":"2017","journal-title":"Cell Physiol. Biochem"},{"key":"10.1016\/j.prp.2025.156109_bib468","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuroscience.2020.12.026","article-title":"Alpha-asarone improves cognitive function of APP\/PS1 Mice and reducing A\u03b242, P-tau and neuroinflammation, and promoting neuron survival in the hippocampus","volume":"458","author":"Zeng","year":"2021","journal-title":"Neuroscience"},{"key":"10.1016\/j.prp.2025.156109_bib469","first-page":"20658","article-title":"\u03b2-asarone prevents A\u03b225-35-induced inflammatory responses and autophagy in SH-SY5Y cells: down expression Beclin-1, LC3B and up expression Bcl-2","volume":"8","author":"Chang","year":"2015","journal-title":"Int J. Clin. Exp. Med"},{"issue":"2095","key":"10.1016\/j.prp.2025.156109_bib470","article-title":"\u03b2-asarone modulates Beclin-1, LC3 and p62 expression to attenuate A\u03b240 and A\u03b242 levels in APP\/PS1 transgenic mice with Alzheimer\u2019s disease","volume":"21","author":"Deng","year":"2020","journal-title":"Mol. Med Rep."},{"key":"10.1016\/j.prp.2025.156109_bib471","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s11011-020-00587-2","article-title":"\u03b2-Asarone improves learning and memory in A\u03b21-42-induced Alzheimer\u2019s disease rats by regulating PINK1-Parkin-mediated mitophagy","volume":"35","author":"Han","year":"2020","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.prp.2025.156109_bib472","article-title":"Non-pharmacological treatment of Alzheimer\u2019s disease: an update","volume":"17","author":"Wang","year":"2025","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.prp.2025.156109_bib473","first-page":"116","article-title":"Non-pharmacologic interventions for persons with dementia","volume":"114","author":"Berg-Weger","year":"2017","journal-title":"Mo Med"},{"key":"10.1016\/j.prp.2025.156109_bib474","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","article-title":"Dementia prevention, intervention, and care: 2020 report of the Lancet Commission","volume":"396","author":"Livingston","year":"2020","journal-title":"Lancet (Lond. Engl. )"},{"key":"10.1016\/j.prp.2025.156109_bib475","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.brs.2019.06.003","article-title":"Effects of 6-month at-home transcranial direct current stimulation on cognition and cerebral glucose metabolism in Alzheimer\u2019s disease","volume":"12","author":"Im","year":"2019","journal-title":"Brain Stimul."},{"key":"10.1016\/j.prp.2025.156109_bib476","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.brs.2014.11.020","article-title":"Deep brain stimulation influences brain structure in Alzheimer\u2019s disease","volume":"8","author":"Sankar","year":"2015","journal-title":"Brain Stimul."},{"key":"10.1016\/j.prp.2025.156109_bib477","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.neuroimage.2017.12.048","article-title":"Transcranial magnetic stimulation of the precuneus enhances memory and neural activity in prodromal Alzheimer\u2019s disease","volume":"169","author":"Koch","year":"2018","journal-title":"Neuroimage"},{"key":"10.1016\/j.prp.2025.156109_bib478","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.14336\/AD.2021.0510","article-title":"The applications of focused ultrasound (FUS) in alzheimer\u2019s disease treatment: a systematic review on both animal and human studies","volume":"12","author":"Liu","year":"2021","journal-title":"Aging Dis."},{"key":"10.1016\/j.prp.2025.156109_bib479","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13195-024-01484-x","article-title":"Photobiomodulation in experimental models of Alzheimer\u2019s disease: state-of-the-art and translational perspectives","volume":"16","author":"Huang","year":"2024","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.prp.2025.156109_bib480","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3349\/ymj.2017.58.1.131","article-title":"Hyperbaric oxygen pretreatment improves cognition and reduces hippocampal damage via p38 mitogen-activated protein kinase in a rat model","volume":"58","author":"Zhao","year":"2017","journal-title":"Yonsei Med J."},{"key":"10.1016\/j.prp.2025.156109_bib481","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2020.594432","article-title":"Overview of meta-analyses of five non-pharmacological interventions for Alzheimer\u2019s disease","volume":"12","author":"Wang","year":"2020","journal-title":"Front. Aging Neurosci."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825003024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825003024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T14:43:37Z","timestamp":1753800217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033825003024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":481,"alternative-id":["S0344033825003024"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2025.156109","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unravelling the Alzheimer's pathogenesis: Molecular and cellular pathways to neurodegeneration and therapeutic targets","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2025.156109","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156109"}}